UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

 Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended: September 30, 2023

 

or

 

 Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from ______ to_______

 

Commission File No. 001-35927

 

AIR INDUSTRIES GROUP

(Exact name of registrant as specified in its charter)

 

Nevada   80-0948413
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

1460 Fifth Avenue, Bay Shore, New York 11706

(Address of principal executive offices)

 

(631) 968-5000

(Registrant’s telephone number, including area code)

 

Securities Registered pursuant to Section 12(b) of the Act

 

Title of Each Class   Trading Symbol(s)   Name of each Exchange on
which Registered
Common Stock   AIRI   NYSE-American

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

 

Indicate by check mark whether the registrant has submitted every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large Accelerated Filer  ☐ Non-Accelerated Filer ☒
Accelerated Filer  ☐ Smaller Reporting Company
  Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No 

 

There were 3,303,045 shares of the registrant’s common stock outstanding as of December 1, 2023.

 

 

 

 

 

 

INDEX

 

      Page No.
PART I. FINANCIAL INFORMATION   1
     
Item 1. Financial Statements    
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   18
     
Item 4. Controls and Procedures   25
     
PART II.  OTHER INFORMATION   26
       
Item 1A. Risk Factors   26
       
Item 6. Exhibits   26
     
SIGNATURES   27

 

i

 

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, or Securities Act, and Section 21E of the Securities Exchange Act of 1934, or Exchange Act. Forward-looking statements are predictive in nature and can be identified by the fact that they do not relate strictly to historical or current facts and generally include words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates” and similar expressions. Certain of the matters discussed herein concerning, among other items, our operations, cash flows, financial position and economic performance including, in particular, future sales, product demand, competition and the effect of economic conditions, include forward-looking statements.

 

These statements and other projections contained herein expressing opinions about future outcomes and non-historical information, are subject to uncertainties and, therefore, there is no assurance that the outcomes expressed in these statements will be achieved. Investors are cautioned that forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from the expectations expressed in forward-looking statements contained herein. Given these uncertainties, you should not place any reliance on these forward-looking statements which speak only as of the date hereof. Factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, those discussed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022, and elsewhere in this report and the risks discussed in our other filings with the Securities Exchange Commission.

 

We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required under the securities laws of the United States.

 

ii

 

 

PART I

 

FINANCIAL INFORMATION

 

    Page No.
Item 1. Financial statements    
     
Condensed Consolidated Financial Statements:    
     
Condensed Consolidated Balance Sheets as of September 30, 2023 (unaudited) and December 31, 2022   2
     
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and 2022 (unaudited)   3
     
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2023 and 2022 (unaudited)   4
     
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022 (unaudited)   5
     
Notes to Condensed Consolidated Financial Statements (unaudited)   7

 

1

 

 

AIR INDUSTRIES GROUP

Condensed Consolidated Balance Sheets

 

   September 30,   December 31, 
   2023   2022 
   (unaudited)     
ASSETS        
Current Assets        
Cash  $740,000   $281,000 
Accounts Receivable, Net of Allowance for Credit Loss of $348,000 and $281,000, at September 30, 2023 and December 31, 2022, respectively   5,221,000    9,483,000 
Inventory   31,348,000    31,821,000 
Prepaid Expenses and Other Current Assets   235,000    307,000 
Contract Costs Receivable   296,000    296,000 
Prepaid Taxes   28,000    28,000 
Total Current Assets   37,868,000    42,216,000 
           
Property and Equipment, Net   9,285,000    8,593,000 
Operating Lease Right-Of-Use-Assets   2,024,000    2,473,000 
Deferred Financing Costs, Net, Deposits and Other Assets   542,000    532,000 
           
TOTAL ASSETS  $49,719,000   $53,814,000 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current Liabilities          
Debt - Current Portion  $13,903,000   $14,477,000 
Accounts Payable and Accrued Expenses   7,290,000    7,542,000 
Operating Lease Liabilities - Current Portion   854,000    778,000 
Deferred Gain on Sale - Current Portion   38,000    38,000 
Customer Deposits   3,476,000    781,000 
Total Current Liabilities   25,561,000    23,616,000 
           
Long-Term Liabilities          
Debt - Net of Current Portion   1,156,000    4,629,000 
Subordinated Notes Payable - Related Party   6,162,000    6,162,000 
Operating Lease Liabilities - Net of Current Portion   1,815,000    2,463,000 
Deferred Gain on Sale - Net of Current Portion   76,000    105,000 
TOTAL LIABILITIES   34,770,000    36,975,000 
           
Commitments and Contingencies (see Note 7)   
 
    
 
 
           
Stockholders’ Equity          
Preferred Stock, Par Value $.001 - Authorized 3,000,000 shares, 0 shares outstanding, at both September 30, 2023 and December 31, 2022.   
-
    
-
 
Common Stock - Par Value $.001 - Authorized 6,000,000 shares, 3,289,827 and 3,247,937 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively   3,000    3,000 
Additional Paid-In Capital   82,868,000    82,446,000 
Accumulated Deficit   (67,922,000)   (65,610,000)
TOTAL STOCKHOLDERS’ EQUITY   14,949,000    16,839,000 
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $49,719,000   $53,814,000 

 

See Notes to Condensed Consolidated Financial Statements.

 

2

 

 

AIR INDUSTRIES GROUP
Condensed Consolidated Statements of Operations
(Unaudited)

  

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
                 
Net Sales  $12,293,000   $13,278,000   $38,047,000   $39,348,000 
                     
Cost of Sales   11,065,000    11,036,000    32,769,000    32,606,000 
                     
Gross Profit   1,228,000    2,242,000    5,278,000    6,742,000 
                     
Operating Expenses   2,024,000    2,073,000    6,160,000    6,116,000 
                     
(Loss) Income from Operations   (796,000)   169,000    (882,000)   626,000 
                     
Interest and Financing Costs   (398,000)   (205,000)   (1,118,000)   (566,000)
                     
Interest Expense - Related Parties   (118,000)   (118,000)   (354,000)   (369,000)
                     
Other Income, Net   13,000    12,000    42,000    132,000 
                     
Loss before Provision For Income Taxes   (1,299,000)   (142,000)   (2,312,000)   (177,000)
                     
Provision for Income Taxes   
-
    
-
    
-
    
-
 
                     
Net Loss  $(1,299,000)  $(142,000)  $(2,312,000)  $(177,000)
                     
Loss per share - Basic and diluted
  $(0.40)  $(0.04)  $(0.71)  $(0.05)
                     
Weighted Average Shares Outstanding - Basic and diluted
   3,286,682    3,232,467    3,270,399    3,224,912 

 

See Notes to Condensed Consolidated Financial Statements.

 

3

 

 

AIR INDUSTRIES GROUP

Condensed Consolidated Statements of Changes in Stockholders’ Equity

For the Three and Nine Months Ended September 30, 2023 and 2022

(Unaudited)

 

           Additional       Total 
   Common Stock   Paid-in   Accumulated   Stockholders’ 
   Shares   Amount   Capital   Deficit   Equity 
Balance, January 1, 2023   3,247,937   $3,000   $82,446,000   $(65,610,000)  $16,839,000 
                          
Common Stock issued for directors fees   11,430    
-
    54,000    
-
    54,000 
Stock Compensation Expense   -    
-
    45,000    
-
    45,000 
Net Loss   -    
-
    
-
    (618,000)   (618,000)
Balance, March 31, 2023   3,259,367   $3,000   $82,545,000   $(66,228,000)  $16,320,000 
                          
Common Stock issued for directors fees   15,230    
-
    54,000    
-
    54,000 
Stock Compensation Expense   -    
-
    187,000    
-
    187,000 
Net Loss   -    
-
    
-
    (395,000)   (395,000)
Balance, June 30, 2023   3,274,597   $3,000   $82,786,000   $(66,623,000)  $16,166,000 
                          
Common Stock issued for directors fees   15,230    
-
    54,000    
-
    54,000 
Stock Compensation Expense   -    
-
    28,000    
-
    28,000 
Net Loss   -    
-
    
-
    (1,299,000)   (1,299,000)
Balance, September 30, 2023   3,289,827   $3,000   $82,868,000   $(67,922,000)  $14,949,000 
                          
Balance January 1, 2022   3,212,801   $3,000   $81,920,000   $(64,534,000)  $17,389,000 
Common Stock issued for directors fees   5,522    
-
    54,000    
-
    54,000 
Stock Compensation Expense   -    
-
    66,000    
-
    66,000 
Net Loss   -    
-
    
-
    (28,000)   (28,000)
Balance, March 31, 2022   3,218,323   $3,000   $82,040,000   $(64,562,000)  $17,481,000 
                          
Common Stock issued for directors fees   6,429    
-
    54,000    
-
    54,000 
Stock Compensation Expense   -    
-
    141,000    
-
    141,000 
Net Loss   -    
-
    
-
    (7,000)   (7,000)
Balance, June 30, 2022   3,224,752   $3,000   $82,235,000   $(64,569,000)  $17,669,000 
                          
Common Stock issued for directors fees   7,715    
-
    54,000    
-
    54,000 
Stock Compensation Expense   -    
-
    55,000    
-
    55,000 
Net Loss   -    
-
    
-
    (142,000)   (142,000)
Balance, September 30, 2022   3,232,467   $3,000   $82,344,000   $(64,711,000)  $17,636,000 

 

See Notes to Condensed Consolidated Financial Statements.

 

4

 

 

AIR INDUSTRIES GROUP

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30,
(Unaudited)

 

   2023   2022 
         
CASH FLOWS FROM OPERATING ACTIVITIES        
Net Loss  $(2,312,000)  $(177,000)
Adjustments to reconcile net loss to net cash provided by operating activities          
Depreciation of property and equipment   1,853,000    1,906,000 
Non-cash employee compensation expense   260,000    262,000 
Non-cash directors compensation   162,000    162,000 
Non-cash other income recognized   
-
    (59,000)
Amortization of operating lease right-of-use assets   449,000    403,000 
Deferred gain on sale of real estate   (29,000)   (29,000)
Bad debt expense (recovery)   38,000    (102,000)
Amortization of deferred financing costs   51,000    48,000 
Changes in Operating Assets and Liabilities          
(Increase) Decrease in Operating Assets:          
Accounts receivable   4,224,000    1,917,000 
Inventory   473,000    (3,876,000)
Prepaid expenses and other current assets   72,000    (24,000)
Prepaid taxes   
-
    (3,000)
Deposits and other assets   (20,000)   (74,000)
Increase (Decrease) in Operating Liabilities:          
Accounts payable and accrued expenses   (251,000)   256,000 
Operating lease liabilities   (572,000)   (504,000)
Customer deposits   2,695,000    (179,000)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES   7,093,000    (73,000)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchase of property and equipment   (1,867,000)   (1,980,000)
NET CASH USED IN INVESTING ACTIVITIES   (1,867,000)   (1,980,000)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Note payable - revolver - net - Webster Bank   (4,908,000)   1,641,000 
Proceeds from term loan - Webster Bank   740,000    1,945,000 
Proceeds from term loan - CT Green Bank   393,000    
-
 
Payments of term loan - Webster Bank   (876,000)   (1,430,000)
Payments of deferred financing costs   (25,000)   (20,000)
Payment of subordinated note payable - related party   
-
    (250,000)
Payments of finance lease obligations   (84,000)   (263,000)
Payments of loan payable - financed asset   (7,000)   (5,000)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES   (4,767,000)   1,618,000 
           
NET INCREASE (DECREASE) IN CASH   459,000    (435,000)
CASH AT BEGINNING OF PERIOD   281,000    627,000 
CASH AT END OF PERIOD  $740,000   $192,000 

 

See Notes to Condensed Consolidated Financial Statements.

 

5

 

 

AIR INDUSTRIES GROUP

Condensed Consolidated Statements of Cash Flows For the Nine Months Ended September 30, (Continued)
(Unaudited)

 

   2023   2022 
         
Supplemental cash flow information        
Cash paid during the period for interest  $1,472,000   $895,000 

 

    2023    2022 
           
Supplemental Disclosure of non-cash investing and finance activities          
Acquisition of financed lease asset  $679,000   $
-
 

 

See Notes to Condensed Consolidated Financial Statements.

 

6

 

AIR INDUSTRIES GROUP

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1. FORMATION, BASIS OF PRESENTATION AND GOING CONCERN

 

Organization

 

Air Industries Group is a Nevada corporation (“AIRI”). As of September 30, 2023, and for the three and nine months ended September 30, 2023 and 2022, the accompanying condensed consolidated financial statements presented are those of AIRI, and its wholly-owned subsidiaries; Air Industries Machining Corp. (“AIM”), Nassau Tool Works, Inc. (“NTW”), and The Sterling Engineering Corporation (“Sterling”), (together, the “Company”).

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the Securities and Exchange Commission, from which the accompanying condensed consolidated balance sheet dated December 31, 2022 was derived.

 

Going Concern

 

As of September 30, 2023, the Company had aggregate debt of $13,715,000 payable to Webster Bank. For the nine months ended September 30, 2023, net cash provided by operating activities was $7,093,000. Despite this year-to-date positive operating cash flow, as discussed in further detail in Note 5, the Company was in violation of two of its financial covenants, including the Fixed Charge Coverage Ratio, as a result of the losses incurred by the Company as well as the large increase in interest rates charged on our debt with Webster Bank.

 

In November 2023, we entered into an amended credit facility with Webster Bank to (a) waive such defaults including our failure to maintain a Fixed Charge Coverage Ratio of 0.95 to 1.00 for the fiscal quarter ended September 30, 2023 and (b) reduce the Fixed Charge Coverage Ratio compliance requirements for the fiscal quarters ending December 31, 2023, March 31 and June 30, 2024. This amended credit facility is intended to provide us with additional flexibility to meet future financial covenants.

 

Navigating the current business landscape poses significant challenges. Accurately projecting future financial periods and ensuring covenant compliance has become extremely difficult. We are grappling with supply chain issues, particularly in securing critical inventory essential for fulfilling specific orders. Additionally, the recent Middle East war has heightened geopolitical instability that we expect will cause fluctuations in our future business results.

 

Our future liquidity may be adversely impacted by various risks and uncertainties, including but not limited to the ongoing wars in Ukraine and Israel, other geopolitical volatility, deterioration in the financial markets or defense industries and other macroeconomic events.

 

While we are presently in full compliance with our Webster Facility, the Company has failed to meet its covenants, as amended, during two out of three of last fiscal quarters. Additionally, it is possible, that the Company may not meet its financial covenants in one of the upcoming fiscal quarters over the next twelve months due to either future losses and/or raising interest rates. Therefore, we have classified the term loan that expires on December 30, 2025 as current as of September 30, 2023, in accordance with the guidance in ASC 470-10-45 related to the classification of callable debt. Failure to meet the revised covenants in future periods and secure any necessary waivers raises substantial doubt about the Company’s ability to continue as a going concern within one year after the issuance date of this report. The Company is required to maintain a collection account with Webster Bank into which substantially all of the Company’s cash receipts are remitted. If Webster were to cease lending and keep the funds remitted to the collection account, the Company would lack the funds to continue its operations.

 

The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Note 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Accounts Receivable

 

Accounts receivable are carried at the original invoice amount less an estimate made for credit losses based on a review of all outstanding amounts on a quarterly basis. Management determines the allowance for credit losses by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, current economic conditions and other relevant factors, including specific reserves for certain accounts. Accounts receivable are written off when deemed uncollectible.  Bad debt expenses are recorded in selling, general, and administrative expense.

 

7

 

 

The activity for the allowance for credit losses during the nine months ended September 30, 2023 and 2022 is set forth in the table below

 

   September 30, 
   2023   2022 
Balance, January 1,  $281,000   $594,000 
           
Provision (Reversal)   67,000    (99,000)
Write-offs   
    
 
Balance, September 30  $348,000   $493,000 

 

Inventory Valuation

 

The Company values inventory at the lower of cost on a first-in-first-out basis or estimated net realizable value.

 

The Company generally purchases raw materials and supplies uniquely suited to the production of larger more complex parts, such as landing gear, only when non-cancellable contracts for orders have been received for finished goods. It occasionally produces larger more complex products, such as landing gear, in excess of purchase order quantities in anticipation of future purchase order demand, when it is economically advantageous to do so, since historically this excess has been used in fulfilling future purchase orders. The Company purchases supplies and materials useful in a variety of products as deemed necessary even though orders have not been received. The Company periodically evaluates inventory items not secured by purchase orders and establishes write-downs to estimated net realizable value for excess quantities, slow-moving goods, obsolescence and for other impairments of value.

 

Inventories consist of the following at:

 

   September 30,   December 31, 
   2023   2022 
         
Raw Materials  $4,836,000   $4,198,000 
Work In Progress   16,337,000    20,488,000 
Finished Goods   13,415,000    10,748,000 
Reserve   (3,240,000)   (3,613,000)
Total Inventory  $31,348,000   $31,821,000 

 

Credit and Concentration Risks

 

There were three customers that represented 60.8% and two customers that represented 63.9% of total net sales for the three months ended September 30, 2023 and 2022, respectively. This is set forth in the table below.

 

  Percentage of Sales 
   September 30,   September 30, 
Customer  2023   2022 
         
1   31.9%   ** 
2   18.0%   ** 
3   10.9%   ** 
4   *    40.7%
5   *    23.2%

 

* Customer was less than 10% of sales for the three months ended September 30, 2023
** Customer was less than 10% of sales for the three months ended September 30, 2022

 

There were four customers that represented 62.9% and three customers that represented 68.9% of total sales for the nine months ended September 30, 2023 and 2022, respectively. This is set forth in the table below.

 

  Percentage of Sales 
   September 30,   September 30, 
Customer  2023   2022 
         
1   24.7%   19.5%
2   17.3%   32.5%
3   10.9%   ** 
4   10.0%   ** 
5   *    16.9%

 

* Customer was less than 10% of sales for the nine months ended September 30, 2023
** Customer was less than 10% of sales for the nine months ended September 30, 2022

 

8

 

 

There were three customers that represented 56.7% and 70.3% of gross accounts receivable at September 30, 2023 and December 31, 2022, respectively. This is set forth in the table below.

 

   Percentage of Accounts Receivables 
   September 30,   December 31, 
Customer  2023   2022 
         
1   23.2%   33.1%
2   20.0%   23.6%
3   13.5%   ** 
4   *    13.6%

 

* Customer was less than 10% of accounts receivable at September 30, 2023
** Customer was less than 10% of accounts receivable at September 30, 2022

 

Disaggregation of Revenue

  

The following table summarizes revenue from contracts with customers for the three and nine month periods ending September 30, 2023 and 2022:

 

   Three Months Ended   Nine Months Ended 
Product  September 30,
2023
   September 30,
2022
   September 30,
2023
   September 30,
2022
 
                 
Military  $10,144,000   $11,266,000   $31,513,000   $33,399,000 
Commercial   2,149,000    2,012,000    6,534,000    5,949,000 
                     
Total  $12,293,000   $13,278,000   $38,047,000   $39,348,000 

 

Cash

 

During the period, the Company had occasionally maintained balances in its bank accounts that were in excess of the FDIC limit. The Company has not experienced any losses on these accounts.

 

Major Suppliers

 

The Company has several key sole-source suppliers of various parts or services that are important for one or more of its products. These suppliers are its only source for such parts or services and, therefore, in the event any of them were to go out of business or be unable to provide parts or services for any reason, its business could be severely harmed.

 

Customer Deposits

 

The Company receives advance payments on certain contracts with the remainder of the contract balance due upon shipment of the final product once the customer inspects and approves the product for shipment. At that time, the entire amount will be recognized as revenue and the deposit will be applied to the customer’s invoice.

 

At September 30, 2023 and December 31, 2022, customer deposits were $3,476,000 and $781,000 respectively. The Company recognized revenue of $147,000 and $461,000 during the three and nine months ended September 30, 2023, respectively, that was included in the customer deposits balance as of December 31, 2022. The Company recognized revenue of $73,000 and $126,000 during the three and nine months ended September 30, 2022, respectively, that was included in the customer deposits balance as of December 31, 2021.

 

9

 

 

Backlog

 

Backlog represents executed non-cancellable contracts that represent firm orders that are deliverable over the next 18- month period. As of September 30, 2023, backlog relating to remaining performance obligations in contracts was approximately $66,900,000. We expect to recognize revenue amounts in future periods related to these remaining performance obligations as follows: approximately $11,900,000 to $13,900,000 of our backlog during the remainder of 2023, approximately $48,500,000 from January 1, 2024 through December 31, 2024, and approximately $3,000,000 to $4,500,000 from January 1, 2025 through March 31, 2025. This expectation is based on the Company’s belief that raw material will be delivered on time from its suppliers, and that its customers will accept delivery as scheduled.

 

Contract Costs Receivable

 

Contract costs receivable represent costs to be reimbursed from a terminated contract. Contract costs receivable totals $296,000 at both September 30, 2023 and December 31, 2022.

 

Leases

 

The Company accounts for leases under ASC 842, “Leases.” All leases are required to be recorded on the balance sheet and are classified as either operating leases or finance leases. The lease classification affects the expense recognition in the condensed consolidated statement of operations. Operating lease charges are recorded entirely in operating expenses. Finance lease charges are split, where amortization of the right-of- use asset is recorded in operating expenses and an implied interest component is recorded in interest expense. See Note 4.

 

Earnings (Loss) per share

 

Basic earnings (loss) per share (“EPS”) is computed by dividing the net income (loss) applicable to common stockholders by the weighted-average number of shares of common stock outstanding for the period.

 

For purposes of calculating diluted earnings per common share, the numerator includes net income plus interest on convertible notes payable assumed converted as of the first day of the period. The denominator includes both the weighted-average number of shares of common stock outstanding during the period and the number of common stock equivalents if the inclusion of such common stock equivalents is dilutive. Dilutive common stock equivalents potentially include stock options and warrants using the treasury stock method and convertible notes payable using the if-converted method. 

 

The following securities have been excluded from the calculation as the exercise price was greater than the average market price of the common shares:

 

   Three and Nine Months
Ended
 
   September 30,   September 30, 
   2023   2022 
         
Stock options   462,870    305,350 
Warrants   -    76,000 
    462,870    381,350 

 

10

 

 

The following securities have been excluded from the calculation because the effect of including these potential shares was anti-dilutive due to the net loss incurred during these periods:

 

   Three and Nine Months Ended 
   September 30,   September 30, 
   2023   2022 
         
Stock options   
-
    
-
 
Convertible notes payable   405,800    405,800 
    405,800    405,800 

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with FASB ASC 718, “Compensation – Stock Compensation.” Under the fair value recognition provision of the ASC, stock-based compensation cost is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options and warrants granted using the Black-Scholes-Merton option pricing model. Stock-based compensation expense for employees amounted to $28,000 and $55,000 for the three months ended September 30, 2023 and 2022, respectively, and $260,000 and $262,000 for the nine months ended September 30, 2023 and 2022, respectively. Stock compensation expense for directors amounted to $54,000 and $54,000 for the three months ended September 30, 2023 and 2022, respectively, and $162,000 and $162,000 for the nine months ended September 30, 2023 and 2022, respectively. Stock compensation expense for employees and directors was included in operating expenses on the accompanying Condensed Consolidated Statements of Operations.

 

Recently Issued Accounting Pronouncements

 

Effective January 1, 2023, the Company adopted ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326) (“ASU 2016-13”), which significantly changes how entities will account for credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. ASU 2016-13 replaces the existing incurred loss model with an expected credit loss model that requires entities to estimate an expected lifetime credit loss on most financial assets and certain other instruments. Under ASU 2016-13 credit impairment is recognized as an allowance for credit losses, rather than as a direct write-down of the amortized cost basis of a financial asset. The impairment allowance is a valuation account deducted from the amortized cost basis of financial assets to present the net amount expected to be collected on the financial asset. The allowance for credit losses must be adjusted for management’s current estimate at each reporting date. The new guidance provides no threshold for recognition of impairment allowance. Therefore, entities must also measure expected credit losses on assets that have a low risk of loss. For instance, trade receivables that are either current or not yet due may not require an allowance reserve under currently generally accepted accounting principles, but under the new standard, the Company will have to estimate an allowance for expected credit losses on trade receivables under ASU 2016-13. The adoption of ASU 2016-13 did not have a material effect on the Company’s financial statements.

 

The Company does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed consolidated financial statements.

 

11

 

 

Note 3. PROPERTY AND EQUIPMENT

 

The components of property and equipment at September 30, 2023 and December 31, 2022 consisted of the following:

 

   September 30,   December 31, 
   2023   2022 
         
Land  $300,000   $300,000 
Buildings and Improvements   2,206,000    1,789,000 
Machinery and Equipment   24,681,000    23,566,000 
Finance Lease Right-of-Use Assets - Machinery and Equipment   1,054,000    375,000 
Tools and Instruments   13,972,000    13,744,000 
Automotive Equipment   266,000    266,000 
Furniture and Fixtures   310,000    290,000 
Leasehold Improvements   1,025,000    941,000 
Computers and Software   605,000    604,000 
Total Property and Equipment   44,419,000    41,875,000 
Less: Accumulated Depreciation   (35,134,000)   (33,282,000)
Property and Equipment, net  $9,285,000   $8,593,000 

 

Depreciation expense for the three months ended September 30, 2023 and 2022 was $614,000 and $598,000, respectively. Depreciation expense for the nine months ended September 30, 2023 and 2022 was $1,853,000 and $1,906,000, respectively.

 

Assets held under financed lease obligations are depreciated over the shorter of their related lease terms or their estimated productive lives. Depreciation of assets under finance leases is included in depreciation expense. Accumulated depreciation on these assets was approximately $46,000 and $0 as of September 30, 2023 and December 31, 2022, respectively.

 

Note 4. LEASES

 

The Company has operating leases for leased office and manufacturing facilities. The leases have remaining lease terms of one to five years, some of which include options to extend or terminate the leases.

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30,   September 30,   September 30, 
   2023   2022   2023   2022 
Operating lease cost:  $295,000   $271,000   $839,000   $834,000 
Total lease cost  $295,000   $271,000   $839,000   $834,000 
                     
Other Information                    
Cash paid for amounts included in the measurement lease liability:  $258,000   $250,000   $773,000   $750,000 
Operating cash flow from operating leases  $258,000   $250,000   $773,000   $750,000 

 

   September 30,   December 31, 
   2023   2022 
Weighted Average Remaining Lease Term - in years   2.91    3.64 
Weighted Average discount rate - %   9.06%   8.89%

 

12

 

 

The aggregate undiscounted cash flows of operating lease payments for leases with remaining terms greater than one year are as follows:

 

   Amount 
December 31, 2023 (remainder of year)  $265,000 
December 31, 2024   1,070,000 
December 31, 2025   992,000 
December 31, 2026   730,000 
Total future minimum lease payments   3,057,000 
Less: discount   (388,000)
Total operating lease maturities   2,669,000 
Less: current portion of operating lease liabilities   (854,000)

Total long-term portion of operating lease maturities

  $1,815,000 

 

Note 5. DEBT

 

Notes payable, related party notes payable and finance lease obligations consist of the following:

 

    September 30,     December 31,  
    2023     2022  
             
Revolving loan to Webster Bank   $ 8,444,000     $ 13,352,000  
Term loan, Webster     5,275,000       5,396,000  
Connecticut Green Bank loan     393,000       -  
Finance lease obligations     923,000       328,000  
Loans payable - financed assets     24,000       30,000  
Related party notes payable     6,162,000       6,162,000  
Subtotal     21,221,000       25,268,000  
Less: Current portion     (13, 903,000 )     (14,477,000 )
Long Term Portion   $ 7, 318,000     $ 10,791,000  

 

Webster Bank (“Webster”)

 

The Company has a loan facility (“Webster Facility”) with Webster Bank that expires on December 30, 2025. The Webster Facility, which was first entered into on December 31, 2019, was amended several times, and now provides for a $20,000,000 revolving loan (“Revolving Line of Credit”), a $5,000,000 term loan (“Term Loan”) and a $2,000,000 Equipment Line of Credit, which as it is drawn upon is added to the balance of the Term Loan.

 

On December 15, 2022, the Company made a draw against the capital expenditure line of credit in the amount of $877,913. The principal payments are $10,451 per month commencing in February 2023 with a balloon payment due on December 30, 2025.

 

On January 4, 2023, the Company made an additional draw against the capital expenditure line of credit in the amount of $739,500. The principal payments are $8,804 per month commencing in March 2023 with a balloon payment due on December 30, 2025.

 

13

 

 

As of September 30, 2023, there is currently $8,444,000 outstanding under the Webster Revolving Loan and $5,275,000 under the Webster term loan, inclusive of amounts drawn under the Equipment Line of Credit. Additionally, there is $382,000 remaining available under the equipment line of credit. The below table shows the timing of payments due under the Term Loan:

 

For the year ending  Amount 
December 31, 2023 (remainder of the year)  $236,000 
December 31, 2024   945,000 
December 31, 2025   4,143,000 
Webster Term Loan payable   5,324,000 
Less: debt issuance costs   (49,000)
Total Webster Term Loan payable, net of debt issuance costs   5,275,000 
Less: Current portion of Webster Term Loan payable   5,275,000 
Total long-term portion of Webster Term Loan payable  $
-
 

 

As of December 31, 2022, our debt to Webster in the amount of $18,748,000 consisted of the Webster Revolving Loan in the amount of $13,352,000 and the Webster term loan in the amount of $5,396,000 which included $878,000 drawn on the equipment line of credit. As discussed in Note 1, there is no assurance that the Company will be able to meet its financial covenants in one of the upcoming fiscal quarters over the next twelve months, therefore in accordance with the guidance in ASC 470-10-45 related to the classification of callable debt the entire term loan has been classified as short term as of September 30,2023.

 

Interest expense related to the Webster Facility amounted to approximately $380,000 and $204,000 for the three months ended September 30, 2023 and 2022, respectively, and $1,084,000 and $506,000 for the nine months ended September 30, 2023 and 2022, respectively.

 

The below summarizes historical amendments to the Webster Facility and various terms:

 

For so long as the Webster term loan remains outstanding, if Excess Cash Flow (as defined) is a positive number for any fiscal year the Company shall pay to Webster an amount equal to the lesser of (i) twenty-five percent (25%) of the Excess Cash Flow for such fiscal year and (ii) the outstanding principal balance of the term loan. Such payment shall be made to Webster and applied to the outstanding principal balance of the term loan, on or prior to the April 15 immediately following such fiscal year. The Company made an Excess Cash Flow payment of $854,000 in April 2022 (for fiscal year ended December 31, 2021). As required, the Company provided the calculation for the Excess Cash Flow payment of $195,000 for fiscal year ended December 31, 2022 to Webster prior to the April 15, 2023 deadline for such payment and authorized such payment to be made from the Revolving Loan. On June 13, 2023, Webster applied this payment to the term loan.

 

On May 17, 2022, the Company entered into the Fourth Amendment to the Webster Facility (“Fourth Amendment”). The purpose of the amendment was to increase the Term Loan to $5,000,000, generating proceeds of $1,945,000, reduce the monthly principal installments to be made in respect to the term loan, and establish a capital expenditure line of credit in the amount of $2,000,000 which the Company can draw upon from time to time to finance purchases of machinery and equipment, thereby increasing the amount of capital expenditures that the Company may make each year. The principal payments are $59,524 per month commencing in June 2022 with a balloon payment due on December 30, 2025. In connection with these changes, the Company paid an amendment fee of $20,000.

 

Under the terms of the Webster Facility, both the Webster revolving line of credit and the Webster term loan will bear an interest rate equal to the greater of (i) 3.50% and (ii) a rate per annum equal to the rate per annum published from time to time in the “Money Rates” table of the Wall Street Journal (or such other presentation within The Wall Street Journal as may be adopted hereafter for such information) as the base or prime rate for corporate loans at the nation’s largest commercial bank, less sixty-five hundredths (-0.65%) of one percent per annum. The average interest rate charged was 7.78% and 4.70% the three months ended September 30, 2023 and 2022, respectively and was 7.44% and 3.94% for the nine months ended September 30, 2023 and 2022, respectively.

 

The Webster Facility limits the amount of Capital Expenditures and dividends the Company can pay to its stockholders. Substantially all of the Company’s assets are pledged as collateral under the Webster Facility.

 

All amendment fees paid in connection with the Webster Facility that are for a future benefit of the Company are included in Deferred Financing Costs, Net, Deposits and Other Assets, in the accompanying condensed consolidated balance sheets and are amortized over the term of the loan.

 

14

 

 

The Webster Facility required that the Company maintain a defined Fixed Charge Coverage Ratio of 1.25 to 1.00 at the end of each Fiscal Quarter. On August 4, 2023, the Company entered into the Fifth Amendment to the Webster Facility (“Fifth Amendment”). The amendment waived the default caused by the failure to achieve the required Fixed Charge Coverage Ratio for the Fiscal Quarter ended March 31, 2023 and decreased the required Fixed Charge Coverage Ratio to 0.95 to 1.00 for the Fiscal Quarters ending June 30, 2023 and September 30, 2023. Additionally, the Fifth Amendment increased the amount of purchase money secured Debt (including Finance Leases) the Company is allowed to have outstanding at any time to $2,000,000. In connection with these changes, the Company paid an amendment fee of $10,000.

 

On November 20, 2023, the Company entered into the Sixth Amendment to the Webster Facility (“Sixth Amendment”). The amendment waived the default caused by the failure to achieve the required Fixed Charge Coverage Ratio for the Fiscal Quarter ended September 30, 2023 and the fact that the Company’s Capital Expenditures were in excess of the amount permitted in the Webster Facility. The Sixth Amendment allows for the Fixed Charge Coverage Ratio to be calculated on a rolling basis (w) for the Fiscal Quarter Ending December 31, 2023, three month basis, (x) for the Fiscal Quarter Ending March 31, 2024, six month basis, (y) for the Fiscal Quarter Ending June 30, 2024, nine month basis, and (z) for all other Fiscal Quarters, twelve month basis. Additionally, the Fixed Charge Coverage Ratio shall not be less than (i) 0.95 to 1.00 for the Fiscal Quarters ending June 30, 2023, September 30, 2023, and December 31, 2023, (ii) 1.10 to 1.00 for the Fiscal Quarter ending March 31, 2024, (iii) 1.20 to 1.00 for the Fiscal Quarter ending June 30, 2024, and (iv) 1.25 to 1.00 for all other Fiscal Quarters. The Sixth Amendment has increased the Capital Expenditure limit to $2,500,000 in any Fiscal Year. In connection with these changes, the Company paid an amendment for of $20,000.

 

As a result of the Company’s entry into the Sixth Amendment, the Company was in compliance with all financial covenants of the Webster Facility for the Fiscal Quarter ended September 30, 2023. 

 

Connecticut Green Bank (“Green Bank”)

 

On August 16, 2023, the Company entered into a Financing Agreement with Green Bank, a quasi-public agency of the State of Connecticut, for the installation of solar energy systems including replacing the existing roof (“Project”) at its Sterling facility. Advances are made by Green Bank upon its approval of costs incurred on the Project up to $934,553. As of September 30, 2023, an advance of $393,233 had been made including the payment of Green Bank’s closing costs of $25,233. Interest accrues at the rate of 5% on advances and is capitalized and added to the outstanding principal of the loan. Upon project completion, the cumulative total of the advances and capitalized interest will convert to a 20-year level payment term loan with interest accruing at the rate of 5.75%. Semi-annual payments are projected to be approximately $41,000 inclusive of interest over the 20-year term.

 

Finance Lease Obligations

 

The Company entered into a finance lease in November of 2022 for the purchase of new manufacturing equipment. Additionally, during May of 2023, the Company entered into an additional finance lease for the purchase of additional manufacturing equipment. The obligations for the finance leases totaled $962,000 and $328,000 as of September 30, 2023 and December 31, 2022, respectively. The leases have an average imputed interest rate of 7.32% per annum and are payable monthly with the final payments due between September of 2026 and May of 2030.

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30,   September 30,   September 30, 
   2023   2022   2023   2022 
Finance Lease cost:                    

Amortization of Right-of-Use assets

  $39,000   $
-
   $84,000   $
-
 
Interest on lease liabilities   17,000    
-
    33,000    
-
 
Total lease Costs  $56,000   $
-
   $117,000   $
-
 
                     
Other Information:                    
Cash Paid for amounts included in the measurement lease liabilities:                    
Financing cash flow from finance lease obligations  $39,000   $9,000   $84,000   $9,000 
                     
Supplemental disclosure of non-cash activity                    
Acquisition of finance lease asset  $679,000   $
-
   $679,000   $
-
 

 

15

 

 

As of September 30, 2023, the aggregate future minimum finance lease payments, including imputed interest are as follows:

 

For the year ending  Amount 
December 31, 2023 (remainder of the year)  $56,000 
December 31, 2024   224,000 
December 31, 2025   224,000 
December 31, 2026   199,000 
December 31, 2027   124,000 
December 31, 2028   124,000 
Thereafter   177,000 
Total future minimum finance lease payments   1,128,000 
Less: imputed interest   (205,000)
Less: Current portion   (162,000)
Long-term portion  $761,000 

 

Loan Payable – Financed Asset

 

The Company financed the purchase of a delivery vehicle in July 2020. The loan obligation totaled $24,000 and $30,000 as of September 30, 2023 and December 31, 2022, respectively. The loan bears no interest and a final payment is due and payable for all unpaid principal on July 20, 2026.

 

The future minimum loan payments are as follows:

 

For the year ending  Amount 
December 31, 2023 (remainder of the year)  $3,000 
December 31, 2024   9,000 
December 31, 2025   9,000 
December 31, 2026   4,000 
Loans Payable - financed assets   25,000 
Less: Current portion   (9,000)
Long-term portion  $16,000 

 

Related Party Notes Payable

 

Taglich Brothers, Inc. is a corporation co-founded by two directors of the Company, Michael and Robert Taglich.

 

Taglich Brothers, Inc. has acted as placement agent for various debt and equity financing transactions and has received cash and equity compensation for their services.

 

From 2016 through 2020, the Company entered into various subordinated notes payable and convertible subordinated notes payable with Michael and Robert Taglich. These notes resulted in proceeds to the Company totaling $6,550,000. In connection with these notes, Michael and Robert were issued a total of 355,082 shares of common stock and Taglich Brothers Inc. was issued promissory notes totaling $554,000 for placement agency fees. At December 31, 2020, related party notes payable totaled $6,012,000 and accrued interest totaled $400,000.

 

On January 1, 2021, the related party subordinated notes due to Michael and Robert Taglich and Taglich Brothers, Inc., were amended to include all accrued interest through December 31, 2020 in the principal balance of the notes. Per the terms of the Webster Facility, these notes remain subordinate to the Webster Facility and the outstanding principal amount of the notes and any accrued but unpaid interest is due on July 1, 2026. Approximately $2,732,000 of the related party convertible subordinated notes can be converted at the option of the holder into Common Stock of the Company at $15.00 per share and bears interest at a rate of 6% per annum, while the remaining $2,080,000 of the related party convertible subordinated notes can be converted at the option of the holder into common stock of the Company at $9.30 per share and bears interest rate of 7% per annum. The subordinated notes which are not convertible bear interest at the rate of 12% per annum. There are no periodic principal payments due on the subordinated notes payable and convertible subordinated notes payable. Under the terms of the Webster Facility, as amended, the Company is now allowed, subject to certain limitations, to make principal payments of $250,000 per quarter of this subordinated debt.

 

16

 

 

For the three and nine months ended September 30, 2023 no principal payments have been made on these notes. For the three and nine months ended September 30, 2022, a principal payment of $250,000 was made against the Subordinated Notes due to Michael Taglich. This payment was made pursuant to the conditions set forth in the Webster Facility, as amended.

 

The note holders and the principal balance of the notes of September 30, 2023 are shown below:

 

   Michael
Taglich,
   Robert
Taglich,
   Taglich
Brothers,
     
   Chairman   Director   Inc.   Total 
Convertible Subordinated Notes  $2,666,000   $1,905,000   $241,000   $4,812,000 
Subordinated Notes   1,000,000    350,000    
-
    1,350,000 
Total  $3,666,000   $2,255,000   $241,000   $6,162,000 

 

Interest expense on all related party notes payable for the three months ended September 30, 2023 and 2022 was $118,000 and $118,000, respectively, and $354,000 and $369,000 for the nine months ended September 30, 2023 and 2022, respectively.

 

Note 6. STOCKHOLDERS’ EQUITY

 

Common Stock – Issuance of Securities

 

The Company issued 15,230 and 7,715 shares of common stock in payment of director fees totaling $54,000 and $54,000 for the three months ended September 30, 2023 and 2022, respectively, and 41,890 and 19,666 shares totaling $162,000 and $162,000 for the nine months ended September 30, 2023 and 2022, respectively.

  

During the fourth quarter of 2023, the Company issued 13,218 shares of common stock in payment of directors’ fees totaling $54,000.

 

2022 Equity Incentive Plan

 

At the 2023 annual meeting of shareholders, an amendment to the Air Industries Group 2022 Equity Incentive Plan, was approved. The amendment increased the number of shares of the Company’s common stock, par value $.001 per share, that are available for issuance by 250,000 shares from 100,000 shares to 350,000.

 

Note 7. CONTINGENCIES

 

On October 2, 2018, Contract Pharmacal Corp. (“Contract Pharmacal”) commenced an action, relating to a Sublease entered into between the Company and Contract Pharmacal in May 2018 with respect to the property that was formerly occupied by the Company’s former subsidiary WMI, at 110 Plant Avenue, Hauppauge, New York. In the action Contract Pharmacal sought damages for an amount in excess of $1,000,000 for the Company’s failure to make the entire premises available by the Sublease commencement date. On July 8, 2021, the Court denied Contract Phamacal’s motion for summary judgement. In the Order, the court granted Contract Pharmacal’s Motions to drop its claim for specific performance and to amend its Complaint to reduce its claim for damages to $700,000. Subsequently, Contact Pharmacal moved to amend its Complaint. The Company opposed and the Court denied the request to amend the Complaint. Contract Pharmacal filed a Motion to reargue which the Court denied on November 30, 2021. On March 10, 2022, Contract Pharmacal filed an appeal to the Court’s decision with the Appellate Division which the Company has opposed. The argument of the appeal filed by Contract Pharmacal was heard by the Appellate Division on November 9, 2023. The Appellate Division has yet to render a decision with respect to Contract Phamacal’s appeal. The Company disputes the validity of the claims asserted by Contract Pharmacal and intends to contest them vigorously.

 

Note 8. INCOME TAXES

 

The Company recorded no income tax expense for the three and nine months ended September 30, 2023 and 2022 because the estimated annual effective tax rate was zero. In determining the estimated annual effective income tax rate, the Company analyzes various factors, including projections of the Company’s annual earnings and taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, the ability to use tax credits and net operating loss carry forwards, and available tax planning alternatives.

 

As of September 30, 2023, and December 31, 2022, the Company provided a full valuation allowance against its net deferred tax assets since the Company believes it is more likely than not that its deferred tax assets will not be realized.

 

Note 9. SUBSEQUENT EVENTS

 

On November 21, 2023, the Company received a notice from NYSE American (the “Exchange”) stating that the Company is not in compliance with the continued listing standards of the Exchange under the timely filing criteria included in Section 1007 of the NYSE American Company Guide because the Company failed to file by the extended due date of November 20, 2023, its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Form 10-Q”).

 

In accordance with Section 1007 of the Company Guide, the Company will have six months from the date of the filing delinquency, or until May 20, 2024 (the “Initial Cure Period”), to file the Form 10-Q with the Securities and Exchange Commission. If the Company fails to file the Form 10-Q during the Initial Cure Period, the Exchange may, in its sole discretion, provide an additional six-month cure period depending on the Company’s specific circumstances.

 

Upon filing of the Form 10-Q, the Company will cure this delinquency.

 

17

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and notes to those statements included elsewhere in this Form 10-Q and with the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K, for the year ended December 31, 2022 (the “2022 Form 10-K”). This discussion contains forward-looking statements that involve risks and uncertainties. You should specifically consider the various risk factors identified in this report that could cause actual results to differ materially from those anticipated in these forward-looking statements.

 

Business Overview

 

Air Industries Group is a holding company with three subsidiaries, AIM, NTW and SEC. SEC began manufacturing aircraft components in 1941 – over 80-years ago – for use in World War II. NTW was formed in the early 1960’s and AIM has been in business since 1971. We became a public company in 2005.

 

We manufacture aerospace components primarily for the defense industry. AIM and NTW manufacture structural parts and assemblies focusing on flight safety, including aircraft landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, and other components. SEC makes components and provides services for aircraft jet engines and ground-power turbines.

 

Products of AIM and NTW are currently deployed on a wide range of high-profile military and commercial aircraft including the Sikorsky UH-60 Blackhawk, Lockheed Martin F-35 Joint Strike Fighter, Northrop Grumman E2D Hawkeye, the US Navy F-18 and USAF F-16 and F-15 fighter aircraft. They also make a critical component for the Pratt & Whitney Geared TurboFan (“GTF”) aircraft engine used on commercial airliners. SEC makes products used in jet engines that are used on military and commercial aircraft including the USAF F-15 and F-16, the Airbus A-330 and the Boeing 777, and others, and in addition, a number of ground-power turbine applications.

 

The aerospace market is highly competitive in both the defense and commercial sectors and we face intense competition in all areas of our business. Nearly all of our revenues are derived by producing products to customer specifications after being awarded a contract through a competitive bidding process. As the commercial aerospace and defense industries continue to consolidate and major contractors seek to streamline supply chains by buying more complete sub-assemblies from fewer suppliers, we have sought to remain competitive not only by providing cost-effective world class products and service but also by increasing our ability to produce more complex and complete assemblies for our customers.

 

We are focused on attaining profitability and maintaining positive cash flows from operating activities. We remain resolute on meeting customers’ needs. To take advantage of the long-term growth opportunities we see in our markets, we have made significant capital investments in new equipment. We believe these investments will increase the velocity and efficiency of production, increase the size of product we can make and allow us to offer additional services to our customers. Some of our investment expands our capabilities allowing us to internally process product that was previously outsourced to third party suppliers. We are pleased with the positive responses from our customers about these initiatives.

 

Our ability to operate profitably and generate positive cash flows from operating activities is determined by our ability to win new or renewal contracts and fulfilling these contracts on a timely and cost-effective basis. Winning a contract generally requires that we submit a bid containing fixed prices for the product or products covered by the contract for an agreed upon period of time, sometimes five-years or longer, with negotiated increases to reflect a portion of the impact of inflation. Thus, when submitting bids, we are required to estimate our future costs of production and, since we often rely upon subcontractors, the prices we can obtain from our subcontractors.

  

While our revenues are largely determined by the number of contracts we are awarded, the volume of product delivered and price of product under each contract, our costs are determined by a number of factors. The principal factors impacting our variable costs are the cost of materials and supplies, labor, financing and the efficiency at which we can produce our products. The cost of materials used in the aerospace industry is highly volatile. The invasion of the Ukraine by the Russian Federation and retaliatory measures imposed by the United States, United Kingdom, the European Union and other countries, and the responses of Russia to such measures, have negatively impacted the availability and market price of certain minerals, such as titanium, for which Russia was a source of supply. To obtain necessary raw materials at prices deemed acceptable, we are working with those of our larger customers which have access to sources of metals necessary to manufacture their products not readily available to us or other companies of our size and seeking to qualify new suppliers with our customers. Nevertheless, there can be no assurance that disruptions in the markets for metals will not adversely impact our ability to timely meet the needs of our customers.

 

18

 

 

In addition, the market for the skilled labor we require to operate our plants is highly competitive. Changes in the available pool of labor caused by Covid-19 and life-style changes in response to Covid-19 have not materially adversely impacted our ability to meet our production schedules. Nevertheless, as we seek to grow our business, there can be no assurance that the skilled labor we need to operate our machinery will be available to us or that the costs incurred to maintain our current labor force and those we seek to bring on will not increase.

 

The profit margin of the various products we sell varies based upon a number of factors, including the complexity of the product, the intensity of the competition for such product and, in some cases, the ability to deliver replacement parts on short notice. Thus, in assessing our performance from one period to another, a reader must understand that changes in profit margin can be the result of shifts in the mix of products sold. Our operations have a large percentage of fixed factory overhead. As a result, our profit margins are also highly variable with sales volumes as under-absorption of factory overhead decreases profits.

 

Our revenues are principally determined by orders from our customers for the delivery of product – which we call releases – against LTA’s with those customers. These long-term agreements generally have fixed prices for product with negotiated increases to reflect a portion of the impact of inflation, though over the term of LTAs prices often increase and not all of the increase is covered by agreed upon price protection clauses in our agreements. Our direct costs of production include costs for material, labor, and significant factory overhead; all of these costs may vary based on the efficiency of our factory operations. Our gross profit is highly variable due to the mix of products sold, and by sales volume, which can lead to the over absorption or under absorption of factory overhead costs.

 

Beyond these direct costs of production, we incur general and administrative costs termed Operating Expenses and financing costs for borrowed money, income taxes and miscellaneous income and expense.

 

A very large percentage of the products we produce are used on military as opposed to civilian aircraft. These products can be replacements for aircraft already in the fleet of the armed services or for the production of new aircraft. Reductions to the Defense Department budget and decreased usage of aircraft reduces the demand for both new production and replacement spares and could adversely impact our business and our revenue.

  

RESULTS OF OPERATIONS

  

Selected Financial Information:

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30,   September 30,   September 30, 
   2023   2022   2023   2022 
                 
Net sales  $12,293,000   $13,278,000   $38,047,000   $39,348,000 
Cost of sales   11,065,000    11,036,000    32,769,000    32,606,000 
Gross profit   1,228,000    2,242,000    5,278,000    6,742,000 
Operating expenses   2,024,000    2,073,000    6,160,000    6,116,000 
Interest and financing costs   516,000    323,000    1,472,000    935,000 
Other income, net   13,000    12,000    42,000    132,000 
Provision for income taxes   -    -    -    - 
Net loss  $(1,299,000)  $(142,000)  $(2,312,000)  $(177,000)

 

19

 

 

Balance Sheet Data:

 

   September 30,   December 31, 
   2023   2022 
         
Cash  $740,000   $281,000 
Working capital  $12,307,000   $18,600,000 
Total assets  $49,719,000   $53,814,000 
Total stockholders’ equity  $14,949,000   $16,839,000 

  

Results of Operations for the three months ended September 30, 2023

 

Net Sales:

 

Consolidated net sales for the three months ended September 30, 2023 were $12,293,000, a decrease of $985,000, or 7.4%, compared with $13,278,000 for the three months ended September 30, 2022. The decrease in net sales was primarily due to the timing of certain shipments of large high dollar components and a supply chain issue related to securing raw material for a specific product.

 

As indicated in the table below, three customers represented 60.8% and two customers represented 63.9% of total sales for the three months ended September 30, 2023 and September 30, 2022, respectively.

 

  Percentage of Sales 
Customer  2023   2022 
Sikorsky Aircraft   31.9%   ** 
Boeing   18.0%   ** 
Collins Aerostructures   10.9%   ** 
Goodrich Landing Gear Systems   *    40.7%
United States Department of Defense   *    23.2%

  

* Customer was less than 10% of sales for the three months September 30, 2023
** Customer was less than 10% of sales for the three months September 30, 2022

  

Gross Profit:

 

Consolidated gross profit for the three months ended September 30, 2023 was $1,228,000, a decrease of $1,014,000, or 45.2%, as compared to gross profit of $2,242,000 for the three months ended September 30, 2022. Consolidated gross profit as a percentage of sales was 10.0% and 16.9% for the three months ended September 30, 2023 and 2022, respectively. The decrease in gross profit percentage was attributable to lower sales which led to the under absorption of manufacturing overhead. The decrease in sales for the quarter was primarily the result of a delay in the receipt of raw materials from one of our suppliers related to a specific product which delayed production. Additionally, during 2023 the mix of product that was sold had lower margins than what was sold during 2022.

 

Operating Expense

 

Consolidated operating expenses for the three months ended September 30, 2023 totaled $2,024,000 and decreased by $49,000 or 2.4% compared to $2,073,000 for the three months ended September 30, 2022. The decrease was caused by reductions in compensation and shipping expense. These decreased costs were partially offset by an increase in amounts spent on information technology.

 

20

 

 

Interest and Financing Costs

 

Interest and financing costs for the three months ended September 30, 2023 were $516,000, an increase of $193,000 or 59.8% compared to $323,000 for the three months ended September 30, 2022. This increase was related to increase in debt related to new equipment and higher interest rates charged during the period. The average interest rate charged was 7.78% and 4.70% for the three months ended September 30 2023 and 2022, respectively.

  

Net Loss

 

Net loss for the three months ended September 30, 2023 was $1,299,000, compared to a net loss of $142,000 for the three months ended September 30, 2022 due to the reasons stated above.

 

Results of Operations for the nine months ended September 30, 2023

 

Net Sales:

 

Consolidated net sales for the nine months ended September 30, 2023 were $38,047,000, a decrease of $1,301,000, or 3.3%, compared with $39,348,000 for the nine months ended September 30, 2022. The decrease in net sales was primarily due to the timing of certain shipments of large high dollar components and a supply chain issue related to securing raw material for a specific product.

 

As indicated in the table below, four customers represented 62.6% and three customers represented 68.9% of total sales for the nine months ended September 30, 2023 and September 30, 2022, respectively.

  

  Percentage of Sales 
Customer  2023   2022 
Sikorsky Aircraft   24.4%   19.5%
Goodrich Landing Gear Systems   17.3%   32.5%
RUAG   10.9%   ** 
Boeing   10.0%   ** 
United States Department of Defense   *    16.9%

  

* Customer was less than 10% of sales for the nine months September 30, 2023
** Customer was less than 10% of sales for the nine months September 30, 2022

  

Gross Profit:

 

Consolidated gross profit from operations for the nine months ended September 30, 2023 was $5,278,000, a decrease of $1,464,000, or 21.7%, as compared to gross profit of $6,742,000 for the nine months ended September 30, 2022. Consolidated gross profit as a percentage of sales was 13.9% and 17.1% for the nine months ended September 30, 2023 and 2022, respectively. The decrease in gross profit percentage was attributable to lower sales which led to the under absorption of manufacturing overhead. The decrease in sales in 2023 was partially the result of a delay in the receipt of raw materials from one of our suppliers related to a specific product which delayed production. Additionally, during 2023 the mix of product that was sold had lower margins than what was sold during 2022.

 

21

 

 

Operating Expenses

 

Consolidated operating expenses for the nine months ended September 30, 2023 totaled $6,160,000 and increased by $44,000 or 0.7% compared to $6,116,000 for the nine months ended September 30, 2022. The increase was caused by increases in stock compensation expense and an increase in amounts spent on information technology. These increased costs were partially offset by decreases in compensation and shipping expense.

 

Interest and Financing Costs

 

Interest and financing costs for the nine months ended September 30, 2023 were $1,472,000 an increase of $537,000 or 57.4% compared to $935,000 for the nine months ended September 30, 2022. This increase was related to increase in debt related to new equipment and higher interest rates charged during the period. The average interest rate was 7.44% and 3.94% for the nine month periods ending September 30, 2023 and 2022, respectively

 

Net Loss

 

Net Loss for the nine months ended September 30, 2023 was $2,312,000, compared to net loss of $177,000 for the nine months ended September 30, 2022, for the reasons discussed above.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Our material cash requirements are for debt service, capital expenditures and funding working capital/operating costs.

 

As of September 30, 2023, we have debt service requirements related to:

 

  1) Our Webster Facility of $13,719,000 consisting of a Revolving Loan of $8,444,000 and a term loan in the amount of $5,275,000. During the remainder of fiscal 2023, we are required to pay $236,000 of principal under the term loan.

 

  2) Related party debt consisting of convertible subordinated note payables of $4,812,000 and subordinated note payables of $1,350,000. This debt is not due until July 1, 2026. Under the Webster Facility we are permitted to make principal payments against this debt in the amount of $250,000 per quarter, as long as certain conditions are met.

 

  3) Various equipment leases and contractual obligations related to our normal business, including advances under the facility with Connecticut Green Bank for the installation of solar energy systems including the replacement of the existing roof at our Sterling Facility.

 

We meet our cash requirements with funds provided by a combination of cash generated from operating activities and from our Webster credit facility. Based on our current revenue visibility and strength of our backlog, we believe that we have sufficient liquidity to meet our short-term cash requirements over the next twelve months. On May 17, 2022, we entered into the Fourth Amendment to the Loan and Security Agreement with Webster Bank (“Webster”). The purpose of the amendment was to increase the Term Loan to $5,000,000, reduce the monthly principal installments to be made in respect to the term loan and establish a capital expenditure line of credit in the amount of $2,000,000 which we can draw upon from time to time to finance purchases of machinery and equipment, thereby increasing the amount of capital expenditures we may make each year. During December 2022, we borrowed $878,000 for a capital expenditure and again in January 2023 we borrowed $739,500 for an additional capital expenditure.

 

For so long as the Webster term loan remains outstanding, if Excess Cash Flow (as defined) is a positive amount for any Fiscal Year, we are obligated to pay Webster an amount equal to the lesser of (i) twenty-five percent (25%) of the Excess Cash Flow and (ii) the outstanding principal balance of the term loan. Such payment shall be made to Webster and applied to the outstanding principal balance of the term loan, on or prior to the April 15 immediately following such Fiscal Year. As required, we provided the calculation for the Excess Cash Flow payment of $195,000 for fiscal year ended December 31, 2022 to Webster prior to the April 15, 2023 deadline and authorized such payment to be made from the Revolving Loan. On June 13, 2023, Webster applied this payment to the term loan.

 

On August 4, 2023, we entered into the Fifth Amendment to the Webster Facility (“Fifth Amendment”). The purpose of the amendment was to waive the default caused by the failure to achieve the required Fixed Coverage Charge Ratio for the Fiscal Quarter ended March 31, 2023 and decrease the required Fixed Coverage Charge Ratio to 0.95 to 1.00 for the Fiscal Quarters ending June 30, 2023 and September 30, 2023. Additionally, the Fifth Amendment increased the amount of purchase money secured debt (finance leases) the Company is allowed to have outstanding at any time to $2,000,000. In connection with these changes, we paid an amendment fee of $10,000.

 

22

 

 

On November 20, 2023, we entered into the Sixth Amendment to the Webster Facility (“Sixth Amendment”). The amendment waived the default caused by the failure to achieve the required Fixed Charge Coverage Ratio for the Fiscal Quarter ended September 30, 2023 and the fact that our Capital Expenditures were in excess of the amount permitted in the Webster Facility. The Sixth Amendment allows for the Fixed Charge Coverage Ratio to be calculated on a rolling basis (w) for the Fiscal Quarter Ending December 31, 2023, three month basis, (x) for the Fiscal Quarter Ending March 31, 2024, six month basis, (y) for the Fiscal Quarter Ending June 30, 2024, nine month basis, and (z) for all other Fiscal Quarters, twelve month basis. Additionally, the Fixed Charge Coverage Ratio shall not be less than (i) 0.95 to 1.00 for the Fiscal Quarters ending June 30, 2023, September 30, 2023, and December 31, 2023, (ii) 1.10 to 1.00 for the Fiscal Quarter ending March 31, 2024, (iii) 1.20 to 1.00 for the Fiscal Quarter ending June 30, 2024, and (iv) 1.25 to 1.00 for all other Fiscal Quarters. The Sixth Amendment has increased the Capital Expenditure limit to $2,500,000 in any Fiscal Year. In connection with these changes, the Company paid an amendment for of $20,000.

 

As a result of recent increases in the federal funds and prime borrowing rates, interest rates and related expense under our Webster Facility increased in 2023 compared to 2022 and if rates remain stable or increase in 2023, our interest expense will further increase in 2023 due to the timing of rate increases in 2022. However, such increases are not expected to materially impact our liquidity. Nevertheless, our liquidity may be adversely impacted by various risks and uncertainties, including, but not limited to future and current impacts of global events such as a widespread health crisis, the continuation of the war in the Ukraine, or the conflict in Israel, the outbreak of another conflict or the expansion of the conflict in Israel to other countries, the ongoing tensions between the United States and China, the Russian Federation and certain countries in the Middle East, increases in inflation, disruptions in the labor market and other risks detailed in Part 1, Item 1A of our 2022 Annual Report on Form 10-K.

 

Navigating the current business landscape poses significant challenges. Accurately projecting future financial periods and ensuring covenant compliance has become extremely difficult. We are grappling with supply chain issues, particularly in securing critical inventory essential for fulfilling specific orders. Additionally, the recent Middle East war has heightened geopolitical instability that we expect will cause fluctuations in our future business results.,

 

Our future liquidity may be adversely impacted by various risks and uncertainties, including but not limited to the ongoing wars in Ukraine and Israel, other geopolitical volatility, deterioration in the financial markets or defense industries and other macroeconomic events.

 

While we are presently in full compliance with our Webster Facility, we have failed to meet our covenants, as amended, during two out of three of the last fiscal quarters. Additionally, it is possible, that we may not meet our financial covenants in one of the upcoming fiscal quarters over the next twelve months due to either future losses and /or raising interest rates. Therefore, due to the aforementioned issues, we have classified the term loan that expires on December 30, 2025 as current as of September 30, 2023, in accordance with the guidance in ASC 470-10-45 related to the classification of callable debt. Failure to meet the revised covenants in future periods and secure any necessary waivers raises substantial doubt about the Company’s ability to continue as a going concern within one year after the issuance date of this report. The Company is required to maintain a collection account with Webster Bank into which substantially all of the Company’s cash receipts are remitted. If Webster were to cease lending and keep the funds remitted to the collection account, the Company would lack the funds to continue its operations.

 

The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

In addition to our loan with Webster and Subordinated Notes, we have various equipment leases and contractual obligations of an ongoing nature which we service in the ordinary course out of our cash flow from operations. Substantially all of these obligations are described in the notes to our financial statements included in this report.

 

Changes in our cash flow are discussed further below.

 

Cash Flow

 

The following table summarizes our net cash flow from operating, investing and financing activities for the periods indicated below (in thousands):

 

   Nine months ended 
   September 30, 
   2023   2022 
Cash provided by (used in)        
Operating activities  $7,093   $(73)
Investing activities   (1,867)   (1,980)
Financing activities   (4,767)   1,618 
Net increase (decrease) in cash  $459   $(435)

 

23

 

 

Cash Provided by (Used in) Operating Activities

 

Cash provided by (used in) operating activities primarily consists of our net loss adjusted for certain non-cash items and changes to working capital items.

 

For the nine months ended September 30, 2023, our net loss of $2,312,000 was offset by $2,784,000 of non-cash items consisting primarily of depreciation of property and equipment of $1,853,000, employee and director stock compensation expense of $422,000 and amortization of right-of-use assets of $449,000 which were partially offset by a deferred gain on the sale of real estate in the amount of $29,000.

 

Operating assets and liabilities provided cash during the nine months ended September 30 in the net amount of $6,621,000 consisting primarily of net decreases in accounts receivable, inventory and prepaid expense in the amounts of $4,224,000, $473,000 and $72,000, respectively, and a net increase in customer deposits in the amount of $2,695,000, which were partially offset by an increase in deposits in the amount of $20,000, and decreases in operating lease liabilities and accounts payable and accrued expenses in the amounts of $572,000 and $251,000, respectively. The increase in customer deposits is related to an advance payment by a customer to be used for the procurement of long lead time raw materials this amount will be disbursed during the remainder of 2023 and early 2024.

  

Cash Used in Investing Activities

 

Cash used in investing activities consists of capital expenditures for property and equipment.

 

For the nine months ended September 30, 2023, cash used in investing activities was $1,867,000. This was primarily for the purchase of state-of-the-art machinery.

 

Cash Used in Financing Activities

 

Cash used in financing activities consists of the borrowing and repayments under our credit facilities with our senior lender, Webster, increases in and repayments of finance obligations and other notes payable.

 

For the nine months ended September 30, 2023, cash used in financing activities was $4,767,000. This was comprised of net payments on our Webster revolving loan in the amounts of $4,908,000 and payments of $876,000 on our Webster term loan, $84,000 on our financing lease obligations and $7,000 on our loan payable – financed asset, partially offset by borrowings of $740,000 on our Webster term loan and advances totaling $393,000 on our financing agreement from CT Green Bank.

 

OFF-BALANCE SHEET ARRANGEMENTS

 

We did not have any off-balance sheet arrangements as of September 30, 2023.

 

Critical Accounting Policies and Estimates

 

A critical accounting policy is one that is both important to the portrayal of a company’s financial condition and results of operations and requires management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

 

Our condensed consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), and all applicable U.S. GAAP accounting standards effective as of September 30, 2023 have been taken into consideration in preparing the condensed consolidated financial statements. The preparation of condensed consolidated financial statements requires estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. Some of those estimates are subjective and complex, and, consequently, actual results could differ from those estimates. The following accounting policies and estimates have been highlighted as significant because changes to certain judgments and assumptions inherent in these policies could affect our condensed consolidated financial statements:

 

  Inventory Valuation, which includes the estimates and methodology used in accounting for the transition of production costs to inventory costs. In our financial statements, inventory is reflected at the lower of cost or net realizable value including write-downs for obsolescence, slow moving and excess inventory; and

  

  Income Taxes, which includes the determination of the valuation allowance for deferred tax assets.

 

We base our estimates, to the extent possible, on historical experience. Historical information is modified as appropriate based on current business factors and various assumptions that we believe are necessary to form a basis for making judgments about the carrying value of assets and liabilities. We evaluate our estimates on an on-going basis and make changes when necessary. Actual results could differ from our estimates.

 

Recently Issued Accounting Pronouncements

 

See Note 2 of the Condensed Consolidated Financial Statements for a discussion of recently issued accounting pronouncements.

 

24

 

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Management is responsible for establishing and maintaining adequate internal controls over financial reporting. Internal controls over financial reporting, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, refers to those policies and procedures and processes that pertain to the maintenance of records that accurately and fairly reflect transactions with respect to our assets; provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles and that receipts and expenditures are made only in accordance with authorization of our management; and provide reasonable assurance regarding the prevention and timely detection of unauthorized transactions with respect to our assets that could have a material effect on our financial statements.

 

Because of inherent limitation, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Our management relies upon the criteria established in the Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) in designing a system intended to meet the needs of our Company and provide reasonable assurance for its assessment.

 

Based on an evaluation of our internal controls over financial reporting for the nine months ended September 30, 2023, our Chief Executive Officer and Chief Financial Officer concluded that our internal controls over financial reporting were not effective as of September 30, 2023. In our 2022 Form 10-K, we reported certain material weaknesses in our internal controls over financial reporting as of December 31, 2022. During the nine months of 2023, we have established written controls and operating procedures intended to address the issues reported related to determining the appropriate reserves to be taken with respect to our inventory and management’s review controls over the income tax provision in the notes to our financial statements; however, these material weaknesses noted will only be deemed to have been remediated after the new controls and procedures have been in place for a sufficient period of time and management has concluded through appropriate testing that the controls are operating effectively. We are in the process of remediating the material weakness in the design flaw related to a granting access to our IT system. We believe that this remediation will be completed late in the fourth quarter of 2023 or in the first quarter of 2024.

 

Changes in Internal Control over Financial Reporting

 

Except as discussed above, there have not been any changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter which is the subject of this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

  

25

 

 

PART II

 

OTHER INFORMATION

 

Item 1A. Risk Factors.

 

Investors are encouraged to consider the risks described in our 2022 Form 10-K, our Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in this Report and other information publicly disclosed or contained in documents we file with the Securities and Exchange Commission before purchasing our securities.

  

Item 6. Exhibits

   

Exhibit No.    Description
     
10.1   Sixth Amendment to Loan and Security Agreement with Webster Bank National Association, successor by merger to Sterling National Bank, (incorporated herein by reference to by reference to Exhibit 99.1 to the Company’s Report on Form 8-K filed on November 27, 2023.
     
31.1*   Certification of principal executive officer pursuant to Rule 13a-14 or Rule 15d-14 of Securities Exchange Act of 1934.
     
31.2*   Certification of principal financial officer pursuant to Rule 13a-14 or Rule 15d-14 of the Exchange Act of 1934.
     
32.1**   Certification of principal executive officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
     
32.2**   Certification of principal financial officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
     
    XBRL Presentation
     
101.INS   XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

  

*Filed herewith
**Furnished herewith

 

26

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: December 6, 2023

 

  AIR INDUSTRIES GROUP
     
  By: /s/ Scott Glassman
    Scott Glassman
Chief Financial Officer
(principal financial and accounting officer)

 

 

27

 

NYSEAMER 0.04 0.05 0.40 0.71 3224912 3232467 3270399 3286682 13903000 7318000 false --12-31 Q3 0001009891 0001009891 2023-01-01 2023-09-30 0001009891 2023-12-01 0001009891 2023-09-30 0001009891 2022-12-31 0001009891 2023-07-01 2023-09-30 0001009891 2022-07-01 2022-09-30 0001009891 2022-01-01 2022-09-30 0001009891 us-gaap:CommonStockMember 2022-12-31 0001009891 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001009891 us-gaap:RetainedEarningsMember 2022-12-31 0001009891 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001009891 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001009891 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001009891 2023-01-01 2023-03-31 0001009891 us-gaap:CommonStockMember 2023-03-31 0001009891 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001009891 us-gaap:RetainedEarningsMember 2023-03-31 0001009891 2023-03-31 0001009891 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001009891 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001009891 2023-04-01 2023-06-30 0001009891 us-gaap:CommonStockMember 2023-06-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001009891 us-gaap:RetainedEarningsMember 2023-06-30 0001009891 2023-06-30 0001009891 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001009891 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001009891 us-gaap:CommonStockMember 2023-09-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001009891 us-gaap:RetainedEarningsMember 2023-09-30 0001009891 us-gaap:CommonStockMember 2021-12-31 0001009891 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001009891 us-gaap:RetainedEarningsMember 2021-12-31 0001009891 2021-12-31 0001009891 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001009891 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001009891 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001009891 2022-01-01 2022-03-31 0001009891 us-gaap:CommonStockMember 2022-03-31 0001009891 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001009891 us-gaap:RetainedEarningsMember 2022-03-31 0001009891 2022-03-31 0001009891 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001009891 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001009891 2022-04-01 2022-06-30 0001009891 us-gaap:CommonStockMember 2022-06-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001009891 us-gaap:RetainedEarningsMember 2022-06-30 0001009891 2022-06-30 0001009891 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001009891 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001009891 us-gaap:CommonStockMember 2022-09-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001009891 us-gaap:RetainedEarningsMember 2022-09-30 0001009891 2022-09-30 0001009891 srt:MinimumMember 2023-01-01 2023-09-30 0001009891 srt:MaximumMember 2023-01-01 2023-09-30 0001009891 airi:ThreeCustomersMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001009891 airi:TwoCustomersMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001009891 us-gaap:OtherCustomerMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001009891 us-gaap:OtherCustomerMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001009891 airi:FourCustomersMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001009891 airi:ThreeCustomersMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001009891 us-gaap:OtherCustomerMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001009891 us-gaap:OtherCustomerMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001009891 airi:ThreeCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001009891 airi:ThreeCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001009891 us-gaap:OtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001009891 us-gaap:OtherCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001009891 srt:ScenarioForecastMember 2024-01-01 2024-12-31 0001009891 srt:MinimumMember srt:ScenarioForecastMember 2025-01-01 2025-12-31 0001009891 srt:MaximumMember srt:ScenarioForecastMember 2025-01-01 2025-12-31 0001009891 2022-01-01 2022-12-31 0001009891 srt:DirectorMember 2023-01-01 2023-09-30 0001009891 srt:DirectorMember 2022-01-01 2022-09-30 0001009891 airi:CustomerOneMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001009891 airi:CustomerOneMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001009891 airi:CustomersTwoMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001009891 airi:CustomersTwoMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001009891 airi:CustomersThreeMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2023-07-01 2023-09-30 0001009891 airi:CustomersThreeMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2022-07-01 2022-09-30 0001009891 airi:CustomersFourMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2023-07-01 2023-09-30 0001009891 airi:CustomersFourMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2022-07-01 2022-09-30 0001009891 airi:CustomersFiveMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2023-07-01 2023-09-30 0001009891 airi:CustomersFiveMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2022-07-01 2022-09-30 0001009891 airi:CustomerOneMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-09-30 0001009891 airi:CustomerOneMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2022-01-01 2022-09-30 0001009891 airi:CustomersTwoMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-09-30 0001009891 airi:CustomersTwoMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2022-01-01 2022-09-30 0001009891 airi:CustomersThreeMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-09-30 0001009891 airi:CustomersThreeMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2022-01-01 2022-09-30 0001009891 airi:CustomersFourMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-09-30 0001009891 airi:CustomersFourMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2022-01-01 2022-09-30 0001009891 airi:CustomersFiveMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-09-30 0001009891 airi:CustomersFiveMember us-gaap:SalesMember us-gaap:CreditConcentrationRiskMember 2022-01-01 2022-09-30 0001009891 airi:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-09-30 0001009891 airi:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2022-01-01 2022-12-31 0001009891 airi:CustomersTwoMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-09-30 0001009891 airi:CustomersTwoMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2022-01-01 2022-12-31 0001009891 airi:CustomersThreeMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-09-30 0001009891 airi:CustomersThreeMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2022-01-01 2022-12-31 0001009891 airi:CustomersFourMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2023-01-01 2023-09-30 0001009891 airi:CustomersFourMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2022-01-01 2022-12-31 0001009891 airi:MilitaryMember 2023-07-01 2023-09-30 0001009891 airi:MilitaryMember 2022-07-01 2022-09-30 0001009891 airi:MilitaryMember 2023-01-01 2023-09-30 0001009891 airi:MilitaryMember 2022-01-01 2022-09-30 0001009891 airi:CommercialMember 2023-07-01 2023-09-30 0001009891 airi:CommercialMember 2022-07-01 2022-09-30 0001009891 airi:CommercialMember 2023-01-01 2023-09-30 0001009891 airi:CommercialMember 2022-01-01 2022-09-30 0001009891 us-gaap:PropertyPlantAndEquipmentMember 2023-09-30 0001009891 us-gaap:PropertyPlantAndEquipmentMember 2022-12-31 0001009891 us-gaap:LandMember 2023-09-30 0001009891 us-gaap:LandMember 2022-12-31 0001009891 us-gaap:BuildingImprovementsMember 2023-09-30 0001009891 us-gaap:BuildingImprovementsMember 2022-12-31 0001009891 us-gaap:MachineryAndEquipmentMember 2023-09-30 0001009891 us-gaap:MachineryAndEquipmentMember 2022-12-31 0001009891 airi:FinanceLeaseRightOfUseAssetsMachineryAndEquipmentMember 2023-09-30 0001009891 airi:FinanceLeaseRightOfUseAssetsMachineryAndEquipmentMember 2022-12-31 0001009891 airi:ToolsAndInstrumentsMember 2023-09-30 0001009891 airi:ToolsAndInstrumentsMember 2022-12-31 0001009891 airi:AutomotiveEquipmentMember 2023-09-30 0001009891 airi:AutomotiveEquipmentMember 2022-12-31 0001009891 us-gaap:FurnitureAndFixturesMember 2023-09-30 0001009891 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001009891 us-gaap:LeaseholdImprovementsMember 2023-09-30 0001009891 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001009891 us-gaap:ComputerEquipmentMember 2023-09-30 0001009891 us-gaap:ComputerEquipmentMember 2022-12-31 0001009891 srt:MinimumMember 2023-09-30 0001009891 srt:MaximumMember 2023-09-30 0001009891 2019-12-31 0001009891 2022-12-01 2022-12-15 0001009891 2023-02-28 0001009891 2023-02-28 2023-02-28 0001009891 2023-01-04 2023-01-04 0001009891 2023-03-31 2023-03-31 0001009891 airi:WebsterFacilityMember 2022-12-31 0001009891 airi:AprilTwoZeroTwoTwoMember 2021-01-01 2021-12-31 0001009891 2022-05-17 0001009891 2022-05-01 2022-05-17 0001009891 airi:FourthAmendmentMember 2022-05-17 0001009891 airi:SixthAmendmentMember 2023-01-01 2023-09-30 0001009891 2023-08-16 0001009891 airi:WebsterFacilityMember airi:ConnecticutGreenBankMember 2023-09-30 0001009891 airi:ConnecticutGreenBankMember 2023-09-30 0001009891 airi:November2022Member 2022-01-01 2022-12-31 0001009891 airi:November2022Member 2023-09-30 0001009891 airi:December2021Member 2023-01-01 2023-09-30 0001009891 airi:December2021Member 2022-01-01 2022-12-31 0001009891 airi:From2016Through2020Member 2023-01-01 2023-09-30 0001009891 airi:From2016Through2020Member 2023-09-30 0001009891 2020-12-31 0001009891 airi:MichaelTaglichAndRobertMember 2020-01-01 2020-12-31 0001009891 airi:MichaelTaglichAndRobertMember 2023-09-30 0001009891 airi:MichaelTaglichAndRobertMember 2023-01-01 2023-09-30 0001009891 airi:MichaelTaglichMember 2023-09-30 0001009891 us-gaap:ObligationsMember 2023-09-30 0001009891 us-gaap:LoansPayableMember 2023-09-30 0001009891 airi:MichaelTaglichChairmanMember 2023-06-30 0001009891 airi:RobertTaglichDirectorMember 2023-06-30 0001009891 airi:TaglichBrothersIncMember 2023-06-30 0001009891 srt:ScenarioForecastMember 2023-10-01 2023-12-31 0001009891 us-gaap:CommonStockMember 2023-09-30 0001009891 airi:TwoThousandTwentyTwoEquityIncentivePlanMember us-gaap:CommonStockMember 2023-09-30 0001009891 srt:MinimumMember airi:TwoThousandTwentyTwoEquityIncentivePlanMember us-gaap:CommonStockMember 2023-09-30 0001009891 srt:MaximumMember airi:TwoThousandTwentyTwoEquityIncentivePlanMember us-gaap:CommonStockMember 2023-09-30 0001009891 2018-10-02 2018-10-02 0001009891 2021-07-08 2021-07-08 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(a) UNDER THE EXCHANGE ACT

 

I, Luciano Melluzzo, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Air Industries Group;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: December 6, 2023  
   
/s/ Luciano Melluzzo  
Luciano Melluzzo  
Chief Executive Officer (Principal Executive Officer)  

 

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a) UNDER THE EXCHANGE ACT

 

I, Scott Glassman, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Air Industries Group;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: December 6, 2023  
   
/s/ Scott Glassman  
Scott Glassman  
Chief Financial Officer (Principal Financial Officer)  

 

 

Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

 

In connection with the Quarterly Report of Air Industries Group, a Nevada corporation (the “Company”), on Form 10-Q for the period ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”) Luciano Melluzzo, Chief Executive Officer of the Company, does hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. ss. 1350), that:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Dated: December 6, 2023

 

/s/ Luciano Melluzzo  
Luciano Melluzzo  
Chief Executive Officer (Principal Executive Officer)  

 

[A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.]

 

Exhibit 32.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

 

In connection with the Quarterly Report of Air Industries Group, a Nevada corporation (the “Company”), on Form 10-Q for the period ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), Scott Glassman, Chief Financial Officer of the Company, does hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. ss. 1350), that:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Dated: December 6, 2023

 

/s/ Scott Glassman  

Scott Glassman

Chief Financial Officer (Principal Financial Officer)

 

 

[A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company. and furnished to the Securities and Exchange Commission or its staff upon request.]

 

 

v3.23.3
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2023
Dec. 01, 2023
Document Information Line Items    
Entity Registrant Name AIR INDUSTRIES GROUP  
Trading Symbol AIRI  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   3,303,045
Amendment Flag false  
Entity Central Index Key 0001009891  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-35927  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 80-0948413  
Entity Address, Address Line One 1460 Fifth Avenue  
Entity Address, Address Line Two Bay Shore  
Entity Address, State or Province NY  
Entity Address, City or Town New York  
Entity Address, Postal Zip Code 11706  
City Area Code (631)  
Local Phone Number 968-5000  
Title of 12(b) Security Common Stock  
Security Exchange Name NYSEAMER  
Entity Interactive Data Current Yes  
v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets    
Cash $ 740,000 $ 281,000
Accounts Receivable, Net of Allowance for Credit Loss of $348,000 and $281,000, at September 30, 2023 and December 31, 2022, respectively 5,221,000 9,483,000
Inventory 31,348,000 31,821,000
Prepaid Expenses and Other Current Assets 235,000 307,000
Contract Costs Receivable 296,000 296,000
Prepaid Taxes 28,000 28,000
Total Current Assets 37,868,000 42,216,000
Property and Equipment, Net 9,285,000 8,593,000
Operating Lease Right-Of-Use-Assets 2,024,000 2,473,000
Deferred Financing Costs, Net, Deposits and Other Assets 542,000 532,000
TOTAL ASSETS 49,719,000 53,814,000
Current Liabilities    
Debt - Current Portion 13,903,000 14,477,000
Accounts Payable and Accrued Expenses 7,290,000 7,542,000
Operating Lease Liabilities - Current Portion 854,000 778,000
Deferred Gain on Sale - Current Portion 38,000 38,000
Customer Deposits 3,476,000 781,000
Total Current Liabilities 25,561,000 23,616,000
Long-Term Liabilities    
Debt - Net of Current Portion 1,156,000 4,629,000
Subordinated Notes Payable - Related Party 6,162,000 6,162,000
Operating Lease Liabilities - Net of Current Portion 1,815,000 2,463,000
Deferred Gain on Sale - Net of Current Portion 76,000 105,000
TOTAL LIABILITIES 34,770,000 36,975,000
Commitments and Contingencies (see Note 7)
Stockholders’ Equity    
Preferred Stock, Par Value $.001 - Authorized 3,000,000 shares, 0 shares outstanding, at both September 30, 2023 and December 31, 2022.
Common Stock - Par Value $.001 - Authorized 6,000,000 shares, 3,289,827 and 3,247,937 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively 3,000 3,000
Additional Paid-In Capital 82,868,000 82,446,000
Accumulated Deficit (67,922,000) (65,610,000)
TOTAL STOCKHOLDERS’ EQUITY 14,949,000 16,839,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 49,719,000 $ 53,814,000
v3.23.3
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts (in Dollars) $ 348,000 $ 281,000
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 3,000,000 3,000,000
Preferred stock, shares outstanding 0 0
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 6,000,000 6,000,000
Common stock, shares issued 3,289,827 3,247,937
Common stock, shares outstanding 3,289,827 3,247,937
v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net Sales $ 12,293,000 $ 13,278,000 $ 38,047,000 $ 39,348,000
Cost of Sales 11,065,000 11,036,000 32,769,000 32,606,000
Gross Profit 1,228,000 2,242,000 5,278,000 6,742,000
Operating Expenses 2,024,000 2,073,000 6,160,000 6,116,000
(Loss) Income from Operations (796,000) 169,000 (882,000) 626,000
Interest and Financing Costs (398,000) (205,000) (1,118,000) (566,000)
Interest Expense - Related Parties (118,000) (118,000) (354,000) (369,000)
Other Income, Net 13,000 12,000 42,000 132,000
Loss before Provision For Income Taxes (1,299,000) (142,000) (2,312,000) (177,000)
Provision for Income Taxes
Net Loss $ (1,299,000) $ (142,000) $ (2,312,000) $ (177,000)
Loss per share - Basic and diluted (in Dollars per share) $ (0.4) $ (0.04) $ (0.71) $ (0.05)
Weighted Average Shares Outstanding - Basic and diluted (in Shares) 3,286,682 3,232,467 3,270,399 3,224,912
v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
(Loss) Income per share Diluted $ (0.40) $ (0.04) $ (0.71) $ (0.05)
Weighted Average Shares Outstanding - Diluted 3,286,682 3,232,467 3,270,399 3,224,912
v3.23.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 3,000 $ 81,920,000 $ (64,534,000) $ 17,389,000
Balance (in Shares) at Dec. 31, 2021 3,212,801      
Common Stock issued for directors fees 54,000 54,000
Common Stock issued for directors fees (in Shares) 5,522      
Stock Compensation Expense 66,000 66,000
Net Loss (28,000) (28,000)
Balance at Mar. 31, 2022 $ 3,000 82,040,000 (64,562,000) 17,481,000
Balance (in Shares) at Mar. 31, 2022 3,218,323      
Balance at Dec. 31, 2021 $ 3,000 81,920,000 (64,534,000) 17,389,000
Balance (in Shares) at Dec. 31, 2021 3,212,801      
Net Loss       (177,000)
Balance at Sep. 30, 2022 $ 3,000 82,344,000 (64,711,000) 17,636,000
Balance (in Shares) at Sep. 30, 2022 3,232,467      
Balance at Mar. 31, 2022 $ 3,000 82,040,000 (64,562,000) 17,481,000
Balance (in Shares) at Mar. 31, 2022 3,218,323      
Common Stock issued for directors fees 54,000 54,000
Common Stock issued for directors fees (in Shares) 6,429      
Stock Compensation Expense 141,000 141,000
Net Loss (7,000) (7,000)
Balance at Jun. 30, 2022 $ 3,000 82,235,000 (64,569,000) 17,669,000
Balance (in Shares) at Jun. 30, 2022 3,224,752      
Common Stock issued for directors fees 54,000 54,000
Common Stock issued for directors fees (in Shares) 7,715      
Stock Compensation Expense 55,000 55,000
Net Loss (142,000) (142,000)
Balance at Sep. 30, 2022 $ 3,000 82,344,000 (64,711,000) 17,636,000
Balance (in Shares) at Sep. 30, 2022 3,232,467      
Balance at Dec. 31, 2022 $ 3,000 82,446,000 (65,610,000) 16,839,000
Balance (in Shares) at Dec. 31, 2022 3,247,937      
Common Stock issued for directors fees 54,000 54,000
Common Stock issued for directors fees (in Shares) 11,430      
Stock Compensation Expense 45,000 45,000
Net Loss (618,000) (618,000)
Balance at Mar. 31, 2023 $ 3,000 82,545,000 (66,228,000) 16,320,000
Balance (in Shares) at Mar. 31, 2023 3,259,367      
Balance at Dec. 31, 2022 $ 3,000 82,446,000 (65,610,000) 16,839,000
Balance (in Shares) at Dec. 31, 2022 3,247,937      
Net Loss       (2,312,000)
Balance at Sep. 30, 2023 $ 3,000 82,868,000 (67,922,000) 14,949,000
Balance (in Shares) at Sep. 30, 2023 3,289,827      
Balance at Mar. 31, 2023 $ 3,000 82,545,000 (66,228,000) 16,320,000
Balance (in Shares) at Mar. 31, 2023 3,259,367      
Common Stock issued for directors fees 54,000 54,000
Common Stock issued for directors fees (in Shares) 15,230      
Stock Compensation Expense 187,000 187,000
Net Loss (395,000) (395,000)
Balance at Jun. 30, 2023 $ 3,000 82,786,000 (66,623,000) 16,166,000
Balance (in Shares) at Jun. 30, 2023 3,274,597      
Common Stock issued for directors fees 54,000 54,000
Common Stock issued for directors fees (in Shares) 15,230      
Stock Compensation Expense 28,000 28,000
Net Loss (1,299,000) (1,299,000)
Balance at Sep. 30, 2023 $ 3,000 $ 82,868,000 $ (67,922,000) $ 14,949,000
Balance (in Shares) at Sep. 30, 2023 3,289,827      
v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (2,312,000) $ (177,000)
Adjustments to reconcile net loss to net cash provided by operating activities    
Depreciation of property and equipment 1,853,000 1,906,000
Non-cash employee compensation expense 260,000 262,000
Non-cash directors compensation 162,000 162,000
Non-cash other income recognized (59,000)
Amortization of operating lease right-of-use assets 449,000 403,000
Deferred gain on sale of real estate (29,000) (29,000)
Bad debt expense (recovery) 38,000 (102,000)
Amortization of deferred financing costs 51,000 48,000
(Increase) Decrease in Operating Assets:    
Accounts receivable 4,224,000 1,917,000
Inventory 473,000 (3,876,000)
Prepaid expenses and other current assets 72,000 (24,000)
Prepaid taxes (3,000)
Deposits and other assets (20,000) (74,000)
Increase (Decrease) in Operating Liabilities:    
Accounts payable and accrued expenses (251,000) 256,000
Operating lease liabilities (572,000) (504,000)
Customer deposits 2,695,000 (179,000)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 7,093,000 (73,000)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of property and equipment (1,867,000) (1,980,000)
NET CASH USED IN INVESTING ACTIVITIES (1,867,000) (1,980,000)
CASH FLOWS FROM FINANCING ACTIVITIES    
Note payable - revolver - net - Webster Bank (4,908,000) 1,641,000
Proceeds from term loan - Webster Bank 740,000 1,945,000
Proceeds from term loan - CT Green Bank 393,000
Payments of term loan - Webster Bank (876,000) (1,430,000)
Payments of deferred financing costs (25,000) (20,000)
Payment of subordinated note payable - related party (250,000)
Payments of finance lease obligations (84,000) (263,000)
Payments of loan payable - financed asset (7,000) (5,000)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES (4,767,000) 1,618,000
NET INCREASE (DECREASE) IN CASH 459,000 (435,000)
CASH AT BEGINNING OF PERIOD 281,000 627,000
CASH AT END OF PERIOD 740,000 192,000
Supplemental cash flow information    
Cash paid during the period for interest 1,472,000 895,000
Supplemental Disclosure of non-cash investing and finance activities    
Acquisition of financed lease asset $ 679,000
v3.23.3
Formation, Basis of Presentation and Going Concern
9 Months Ended
Sep. 30, 2023
Formation, Basis of Presentation and Going Concern [Abstract]  
FORMATION, BASIS OF PRESENTATION AND GOING CONCERN

Note 1. FORMATION, BASIS OF PRESENTATION AND GOING CONCERN

 

Organization

 

Air Industries Group is a Nevada corporation (“AIRI”). As of September 30, 2023, and for the three and nine months ended September 30, 2023 and 2022, the accompanying condensed consolidated financial statements presented are those of AIRI, and its wholly-owned subsidiaries; Air Industries Machining Corp. (“AIM”), Nassau Tool Works, Inc. (“NTW”), and The Sterling Engineering Corporation (“Sterling”), (together, the “Company”).

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the Securities and Exchange Commission, from which the accompanying condensed consolidated balance sheet dated December 31, 2022 was derived.

 

Going Concern

 

As of September 30, 2023, the Company had aggregate debt of $13,715,000 payable to Webster Bank. For the nine months ended September 30, 2023, net cash provided by operating activities was $7,093,000. Despite this year-to-date positive operating cash flow, as discussed in further detail in Note 5, the Company was in violation of two of its financial covenants, including the Fixed Charge Coverage Ratio, as a result of the losses incurred by the Company as well as the large increase in interest rates charged on our debt with Webster Bank.

 

In November 2023, we entered into an amended credit facility with Webster Bank to (a) waive such defaults including our failure to maintain a Fixed Charge Coverage Ratio of 0.95 to 1.00 for the fiscal quarter ended September 30, 2023 and (b) reduce the Fixed Charge Coverage Ratio compliance requirements for the fiscal quarters ending December 31, 2023, March 31 and June 30, 2024. This amended credit facility is intended to provide us with additional flexibility to meet future financial covenants.

 

Navigating the current business landscape poses significant challenges. Accurately projecting future financial periods and ensuring covenant compliance has become extremely difficult. We are grappling with supply chain issues, particularly in securing critical inventory essential for fulfilling specific orders. Additionally, the recent Middle East war has heightened geopolitical instability that we expect will cause fluctuations in our future business results.

 

Our future liquidity may be adversely impacted by various risks and uncertainties, including but not limited to the ongoing wars in Ukraine and Israel, other geopolitical volatility, deterioration in the financial markets or defense industries and other macroeconomic events.

 

While we are presently in full compliance with our Webster Facility, the Company has failed to meet its covenants, as amended, during two out of three of last fiscal quarters. Additionally, it is possible, that the Company may not meet its financial covenants in one of the upcoming fiscal quarters over the next twelve months due to either future losses and/or raising interest rates. Therefore, we have classified the term loan that expires on December 30, 2025 as current as of September 30, 2023, in accordance with the guidance in ASC 470-10-45 related to the classification of callable debt. Failure to meet the revised covenants in future periods and secure any necessary waivers raises substantial doubt about the Company’s ability to continue as a going concern within one year after the issuance date of this report. The Company is required to maintain a collection account with Webster Bank into which substantially all of the Company’s cash receipts are remitted. If Webster were to cease lending and keep the funds remitted to the collection account, the Company would lack the funds to continue its operations.

 

The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

v3.23.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Note 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Accounts Receivable

 

Accounts receivable are carried at the original invoice amount less an estimate made for credit losses based on a review of all outstanding amounts on a quarterly basis. Management determines the allowance for credit losses by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, current economic conditions and other relevant factors, including specific reserves for certain accounts. Accounts receivable are written off when deemed uncollectible.  Bad debt expenses are recorded in selling, general, and administrative expense.

 

The activity for the allowance for credit losses during the nine months ended September 30, 2023 and 2022 is set forth in the table below

 

   September 30, 
   2023   2022 
Balance, January 1,  $281,000   $594,000 
           
Provision (Reversal)   67,000    (99,000)
Write-offs   
    
 
Balance, September 30  $348,000   $493,000 

 

Inventory Valuation

 

The Company values inventory at the lower of cost on a first-in-first-out basis or estimated net realizable value.

 

The Company generally purchases raw materials and supplies uniquely suited to the production of larger more complex parts, such as landing gear, only when non-cancellable contracts for orders have been received for finished goods. It occasionally produces larger more complex products, such as landing gear, in excess of purchase order quantities in anticipation of future purchase order demand, when it is economically advantageous to do so, since historically this excess has been used in fulfilling future purchase orders. The Company purchases supplies and materials useful in a variety of products as deemed necessary even though orders have not been received. The Company periodically evaluates inventory items not secured by purchase orders and establishes write-downs to estimated net realizable value for excess quantities, slow-moving goods, obsolescence and for other impairments of value.

 

Inventories consist of the following at:

 

   September 30,   December 31, 
   2023   2022 
         
Raw Materials  $4,836,000   $4,198,000 
Work In Progress   16,337,000    20,488,000 
Finished Goods   13,415,000    10,748,000 
Reserve   (3,240,000)   (3,613,000)
Total Inventory  $31,348,000   $31,821,000 

 

Credit and Concentration Risks

 

There were three customers that represented 60.8% and two customers that represented 63.9% of total net sales for the three months ended September 30, 2023 and 2022, respectively. This is set forth in the table below.

 

  Percentage of Sales 
   September 30,   September 30, 
Customer  2023   2022 
         
1   31.9%   ** 
2   18.0%   ** 
3   10.9%   ** 
4   *    40.7%
5   *    23.2%

 

* Customer was less than 10% of sales for the three months ended September 30, 2023
** Customer was less than 10% of sales for the three months ended September 30, 2022

 

There were four customers that represented 62.9% and three customers that represented 68.9% of total sales for the nine months ended September 30, 2023 and 2022, respectively. This is set forth in the table below.

 

  Percentage of Sales 
   September 30,   September 30, 
Customer  2023   2022 
         
1   24.7%   19.5%
2   17.3%   32.5%
3   10.9%   ** 
4   10.0%   ** 
5   *    16.9%

 

* Customer was less than 10% of sales for the nine months ended September 30, 2023
** Customer was less than 10% of sales for the nine months ended September 30, 2022

 

There were three customers that represented 56.7% and 70.3% of gross accounts receivable at September 30, 2023 and December 31, 2022, respectively. This is set forth in the table below.

 

   Percentage of Accounts Receivables 
   September 30,   December 31, 
Customer  2023   2022 
         
1   23.2%   33.1%
2   20.0%   23.6%
3   13.5%   ** 
4   *    13.6%

 

* Customer was less than 10% of accounts receivable at September 30, 2023
** Customer was less than 10% of accounts receivable at September 30, 2022

 

Disaggregation of Revenue

  

The following table summarizes revenue from contracts with customers for the three and nine month periods ending September 30, 2023 and 2022:

 

   Three Months Ended   Nine Months Ended 
Product  September 30,
2023
   September 30,
2022
   September 30,
2023
   September 30,
2022
 
                 
Military  $10,144,000   $11,266,000   $31,513,000   $33,399,000 
Commercial   2,149,000    2,012,000    6,534,000    5,949,000 
                     
Total  $12,293,000   $13,278,000   $38,047,000   $39,348,000 

 

Cash

 

During the period, the Company had occasionally maintained balances in its bank accounts that were in excess of the FDIC limit. The Company has not experienced any losses on these accounts.

 

Major Suppliers

 

The Company has several key sole-source suppliers of various parts or services that are important for one or more of its products. These suppliers are its only source for such parts or services and, therefore, in the event any of them were to go out of business or be unable to provide parts or services for any reason, its business could be severely harmed.

 

Customer Deposits

 

The Company receives advance payments on certain contracts with the remainder of the contract balance due upon shipment of the final product once the customer inspects and approves the product for shipment. At that time, the entire amount will be recognized as revenue and the deposit will be applied to the customer’s invoice.

 

At September 30, 2023 and December 31, 2022, customer deposits were $3,476,000 and $781,000 respectively. The Company recognized revenue of $147,000 and $461,000 during the three and nine months ended September 30, 2023, respectively, that was included in the customer deposits balance as of December 31, 2022. The Company recognized revenue of $73,000 and $126,000 during the three and nine months ended September 30, 2022, respectively, that was included in the customer deposits balance as of December 31, 2021.

 

Backlog

 

Backlog represents executed non-cancellable contracts that represent firm orders that are deliverable over the next 18- month period. As of September 30, 2023, backlog relating to remaining performance obligations in contracts was approximately $66,900,000. We expect to recognize revenue amounts in future periods related to these remaining performance obligations as follows: approximately $11,900,000 to $13,900,000 of our backlog during the remainder of 2023, approximately $48,500,000 from January 1, 2024 through December 31, 2024, and approximately $3,000,000 to $4,500,000 from January 1, 2025 through March 31, 2025. This expectation is based on the Company’s belief that raw material will be delivered on time from its suppliers, and that its customers will accept delivery as scheduled.

 

Contract Costs Receivable

 

Contract costs receivable represent costs to be reimbursed from a terminated contract. Contract costs receivable totals $296,000 at both September 30, 2023 and December 31, 2022.

 

Leases

 

The Company accounts for leases under ASC 842, “Leases.” All leases are required to be recorded on the balance sheet and are classified as either operating leases or finance leases. The lease classification affects the expense recognition in the condensed consolidated statement of operations. Operating lease charges are recorded entirely in operating expenses. Finance lease charges are split, where amortization of the right-of- use asset is recorded in operating expenses and an implied interest component is recorded in interest expense. See Note 4.

 

Earnings (Loss) per share

 

Basic earnings (loss) per share (“EPS”) is computed by dividing the net income (loss) applicable to common stockholders by the weighted-average number of shares of common stock outstanding for the period.

 

For purposes of calculating diluted earnings per common share, the numerator includes net income plus interest on convertible notes payable assumed converted as of the first day of the period. The denominator includes both the weighted-average number of shares of common stock outstanding during the period and the number of common stock equivalents if the inclusion of such common stock equivalents is dilutive. Dilutive common stock equivalents potentially include stock options and warrants using the treasury stock method and convertible notes payable using the if-converted method. 

 

The following securities have been excluded from the calculation as the exercise price was greater than the average market price of the common shares:

 

   Three and Nine Months
Ended
 
   September 30,   September 30, 
   2023   2022 
         
Stock options   462,870    305,350 
Warrants   -    76,000 
    462,870    381,350 

 

The following securities have been excluded from the calculation because the effect of including these potential shares was anti-dilutive due to the net loss incurred during these periods:

 

   Three and Nine Months Ended 
   September 30,   September 30, 
   2023   2022 
         
Stock options   
-
    
-
 
Convertible notes payable   405,800    405,800 
    405,800    405,800 

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with FASB ASC 718, “Compensation – Stock Compensation.” Under the fair value recognition provision of the ASC, stock-based compensation cost is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options and warrants granted using the Black-Scholes-Merton option pricing model. Stock-based compensation expense for employees amounted to $28,000 and $55,000 for the three months ended September 30, 2023 and 2022, respectively, and $260,000 and $262,000 for the nine months ended September 30, 2023 and 2022, respectively. Stock compensation expense for directors amounted to $54,000 and $54,000 for the three months ended September 30, 2023 and 2022, respectively, and $162,000 and $162,000 for the nine months ended September 30, 2023 and 2022, respectively. Stock compensation expense for employees and directors was included in operating expenses on the accompanying Condensed Consolidated Statements of Operations.

 

Recently Issued Accounting Pronouncements

 

Effective January 1, 2023, the Company adopted ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326) (“ASU 2016-13”), which significantly changes how entities will account for credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. ASU 2016-13 replaces the existing incurred loss model with an expected credit loss model that requires entities to estimate an expected lifetime credit loss on most financial assets and certain other instruments. Under ASU 2016-13 credit impairment is recognized as an allowance for credit losses, rather than as a direct write-down of the amortized cost basis of a financial asset. The impairment allowance is a valuation account deducted from the amortized cost basis of financial assets to present the net amount expected to be collected on the financial asset. The allowance for credit losses must be adjusted for management’s current estimate at each reporting date. The new guidance provides no threshold for recognition of impairment allowance. Therefore, entities must also measure expected credit losses on assets that have a low risk of loss. For instance, trade receivables that are either current or not yet due may not require an allowance reserve under currently generally accepted accounting principles, but under the new standard, the Company will have to estimate an allowance for expected credit losses on trade receivables under ASU 2016-13. The adoption of ASU 2016-13 did not have a material effect on the Company’s financial statements.

 

The Company does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed consolidated financial statements.

v3.23.3
Property and Equipment
9 Months Ended
Sep. 30, 2023
Property and Equipment [Abstract]  
PROPERTY AND EQUIPMENT

Note 3. PROPERTY AND EQUIPMENT

 

The components of property and equipment at September 30, 2023 and December 31, 2022 consisted of the following:

 

   September 30,   December 31, 
   2023   2022 
         
Land  $300,000   $300,000 
Buildings and Improvements   2,206,000    1,789,000 
Machinery and Equipment   24,681,000    23,566,000 
Finance Lease Right-of-Use Assets - Machinery and Equipment   1,054,000    375,000 
Tools and Instruments   13,972,000    13,744,000 
Automotive Equipment   266,000    266,000 
Furniture and Fixtures   310,000    290,000 
Leasehold Improvements   1,025,000    941,000 
Computers and Software   605,000    604,000 
Total Property and Equipment   44,419,000    41,875,000 
Less: Accumulated Depreciation   (35,134,000)   (33,282,000)
Property and Equipment, net  $9,285,000   $8,593,000 

 

Depreciation expense for the three months ended September 30, 2023 and 2022 was $614,000 and $598,000, respectively. Depreciation expense for the nine months ended September 30, 2023 and 2022 was $1,853,000 and $1,906,000, respectively.

 

Assets held under financed lease obligations are depreciated over the shorter of their related lease terms or their estimated productive lives. Depreciation of assets under finance leases is included in depreciation expense. Accumulated depreciation on these assets was approximately $46,000 and $0 as of September 30, 2023 and December 31, 2022, respectively.

v3.23.3
Leases
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
LEASES

Note 4. LEASES

 

The Company has operating leases for leased office and manufacturing facilities. The leases have remaining lease terms of one to five years, some of which include options to extend or terminate the leases.

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30,   September 30,   September 30, 
   2023   2022   2023   2022 
Operating lease cost:  $295,000   $271,000   $839,000   $834,000 
Total lease cost  $295,000   $271,000   $839,000   $834,000 
                     
Other Information                    
Cash paid for amounts included in the measurement lease liability:  $258,000   $250,000   $773,000   $750,000 
Operating cash flow from operating leases  $258,000   $250,000   $773,000   $750,000 

 

   September 30,   December 31, 
   2023   2022 
Weighted Average Remaining Lease Term - in years   2.91    3.64 
Weighted Average discount rate - %   9.06%   8.89%

 

The aggregate undiscounted cash flows of operating lease payments for leases with remaining terms greater than one year are as follows:

 

   Amount 
December 31, 2023 (remainder of year)  $265,000 
December 31, 2024   1,070,000 
December 31, 2025   992,000 
December 31, 2026   730,000 
Total future minimum lease payments   3,057,000 
Less: discount   (388,000)
Total operating lease maturities   2,669,000 
Less: current portion of operating lease liabilities   (854,000)

Total long-term portion of operating lease maturities

  $1,815,000 
v3.23.3
Debt
9 Months Ended
Sep. 30, 2023
Debt [Abstract]  
DEBT

Note 5. DEBT

 

Notes payable, related party notes payable and finance lease obligations consist of the following:

 

    September 30,     December 31,  
    2023     2022  
             
Revolving loan to Webster Bank   $ 8,444,000     $ 13,352,000  
Term loan, Webster     5,275,000       5,396,000  
Connecticut Green Bank loan     393,000       -  
Finance lease obligations     923,000       328,000  
Loans payable - financed assets     24,000       30,000  
Related party notes payable     6,162,000       6,162,000  
Subtotal     21,221,000       25,268,000  
Less: Current portion     (13, 903,000 )     (14,477,000 )
Long Term Portion   $ 7, 318,000     $ 10,791,000  

 

Webster Bank (“Webster”)

 

The Company has a loan facility (“Webster Facility”) with Webster Bank that expires on December 30, 2025. The Webster Facility, which was first entered into on December 31, 2019, was amended several times, and now provides for a $20,000,000 revolving loan (“Revolving Line of Credit”), a $5,000,000 term loan (“Term Loan”) and a $2,000,000 Equipment Line of Credit, which as it is drawn upon is added to the balance of the Term Loan.

 

On December 15, 2022, the Company made a draw against the capital expenditure line of credit in the amount of $877,913. The principal payments are $10,451 per month commencing in February 2023 with a balloon payment due on December 30, 2025.

 

On January 4, 2023, the Company made an additional draw against the capital expenditure line of credit in the amount of $739,500. The principal payments are $8,804 per month commencing in March 2023 with a balloon payment due on December 30, 2025.

 

As of September 30, 2023, there is currently $8,444,000 outstanding under the Webster Revolving Loan and $5,275,000 under the Webster term loan, inclusive of amounts drawn under the Equipment Line of Credit. Additionally, there is $382,000 remaining available under the equipment line of credit. The below table shows the timing of payments due under the Term Loan:

 

For the year ending  Amount 
December 31, 2023 (remainder of the year)  $236,000 
December 31, 2024   945,000 
December 31, 2025   4,143,000 
Webster Term Loan payable   5,324,000 
Less: debt issuance costs   (49,000)
Total Webster Term Loan payable, net of debt issuance costs   5,275,000 
Less: Current portion of Webster Term Loan payable   5,275,000 
Total long-term portion of Webster Term Loan payable  $
-
 

 

As of December 31, 2022, our debt to Webster in the amount of $18,748,000 consisted of the Webster Revolving Loan in the amount of $13,352,000 and the Webster term loan in the amount of $5,396,000 which included $878,000 drawn on the equipment line of credit. As discussed in Note 1, there is no assurance that the Company will be able to meet its financial covenants in one of the upcoming fiscal quarters over the next twelve months, therefore in accordance with the guidance in ASC 470-10-45 related to the classification of callable debt the entire term loan has been classified as short term as of September 30,2023.

 

Interest expense related to the Webster Facility amounted to approximately $380,000 and $204,000 for the three months ended September 30, 2023 and 2022, respectively, and $1,084,000 and $506,000 for the nine months ended September 30, 2023 and 2022, respectively.

 

The below summarizes historical amendments to the Webster Facility and various terms:

 

For so long as the Webster term loan remains outstanding, if Excess Cash Flow (as defined) is a positive number for any fiscal year the Company shall pay to Webster an amount equal to the lesser of (i) twenty-five percent (25%) of the Excess Cash Flow for such fiscal year and (ii) the outstanding principal balance of the term loan. Such payment shall be made to Webster and applied to the outstanding principal balance of the term loan, on or prior to the April 15 immediately following such fiscal year. The Company made an Excess Cash Flow payment of $854,000 in April 2022 (for fiscal year ended December 31, 2021). As required, the Company provided the calculation for the Excess Cash Flow payment of $195,000 for fiscal year ended December 31, 2022 to Webster prior to the April 15, 2023 deadline for such payment and authorized such payment to be made from the Revolving Loan. On June 13, 2023, Webster applied this payment to the term loan.

 

On May 17, 2022, the Company entered into the Fourth Amendment to the Webster Facility (“Fourth Amendment”). The purpose of the amendment was to increase the Term Loan to $5,000,000, generating proceeds of $1,945,000, reduce the monthly principal installments to be made in respect to the term loan, and establish a capital expenditure line of credit in the amount of $2,000,000 which the Company can draw upon from time to time to finance purchases of machinery and equipment, thereby increasing the amount of capital expenditures that the Company may make each year. The principal payments are $59,524 per month commencing in June 2022 with a balloon payment due on December 30, 2025. In connection with these changes, the Company paid an amendment fee of $20,000.

 

Under the terms of the Webster Facility, both the Webster revolving line of credit and the Webster term loan will bear an interest rate equal to the greater of (i) 3.50% and (ii) a rate per annum equal to the rate per annum published from time to time in the “Money Rates” table of the Wall Street Journal (or such other presentation within The Wall Street Journal as may be adopted hereafter for such information) as the base or prime rate for corporate loans at the nation’s largest commercial bank, less sixty-five hundredths (-0.65%) of one percent per annum. The average interest rate charged was 7.78% and 4.70% the three months ended September 30, 2023 and 2022, respectively and was 7.44% and 3.94% for the nine months ended September 30, 2023 and 2022, respectively.

 

The Webster Facility limits the amount of Capital Expenditures and dividends the Company can pay to its stockholders. Substantially all of the Company’s assets are pledged as collateral under the Webster Facility.

 

All amendment fees paid in connection with the Webster Facility that are for a future benefit of the Company are included in Deferred Financing Costs, Net, Deposits and Other Assets, in the accompanying condensed consolidated balance sheets and are amortized over the term of the loan.

 

The Webster Facility required that the Company maintain a defined Fixed Charge Coverage Ratio of 1.25 to 1.00 at the end of each Fiscal Quarter. On August 4, 2023, the Company entered into the Fifth Amendment to the Webster Facility (“Fifth Amendment”). The amendment waived the default caused by the failure to achieve the required Fixed Charge Coverage Ratio for the Fiscal Quarter ended March 31, 2023 and decreased the required Fixed Charge Coverage Ratio to 0.95 to 1.00 for the Fiscal Quarters ending June 30, 2023 and September 30, 2023. Additionally, the Fifth Amendment increased the amount of purchase money secured Debt (including Finance Leases) the Company is allowed to have outstanding at any time to $2,000,000. In connection with these changes, the Company paid an amendment fee of $10,000.

 

On November 20, 2023, the Company entered into the Sixth Amendment to the Webster Facility (“Sixth Amendment”). The amendment waived the default caused by the failure to achieve the required Fixed Charge Coverage Ratio for the Fiscal Quarter ended September 30, 2023 and the fact that the Company’s Capital Expenditures were in excess of the amount permitted in the Webster Facility. The Sixth Amendment allows for the Fixed Charge Coverage Ratio to be calculated on a rolling basis (w) for the Fiscal Quarter Ending December 31, 2023, three month basis, (x) for the Fiscal Quarter Ending March 31, 2024, six month basis, (y) for the Fiscal Quarter Ending June 30, 2024, nine month basis, and (z) for all other Fiscal Quarters, twelve month basis. Additionally, the Fixed Charge Coverage Ratio shall not be less than (i) 0.95 to 1.00 for the Fiscal Quarters ending June 30, 2023, September 30, 2023, and December 31, 2023, (ii) 1.10 to 1.00 for the Fiscal Quarter ending March 31, 2024, (iii) 1.20 to 1.00 for the Fiscal Quarter ending June 30, 2024, and (iv) 1.25 to 1.00 for all other Fiscal Quarters. The Sixth Amendment has increased the Capital Expenditure limit to $2,500,000 in any Fiscal Year. In connection with these changes, the Company paid an amendment for of $20,000.

 

As a result of the Company’s entry into the Sixth Amendment, the Company was in compliance with all financial covenants of the Webster Facility for the Fiscal Quarter ended September 30, 2023. 

 

Connecticut Green Bank (“Green Bank”)

 

On August 16, 2023, the Company entered into a Financing Agreement with Green Bank, a quasi-public agency of the State of Connecticut, for the installation of solar energy systems including replacing the existing roof (“Project”) at its Sterling facility. Advances are made by Green Bank upon its approval of costs incurred on the Project up to $934,553. As of September 30, 2023, an advance of $393,233 had been made including the payment of Green Bank’s closing costs of $25,233. Interest accrues at the rate of 5% on advances and is capitalized and added to the outstanding principal of the loan. Upon project completion, the cumulative total of the advances and capitalized interest will convert to a 20-year level payment term loan with interest accruing at the rate of 5.75%. Semi-annual payments are projected to be approximately $41,000 inclusive of interest over the 20-year term.

 

Finance Lease Obligations

 

The Company entered into a finance lease in November of 2022 for the purchase of new manufacturing equipment. Additionally, during May of 2023, the Company entered into an additional finance lease for the purchase of additional manufacturing equipment. The obligations for the finance leases totaled $962,000 and $328,000 as of September 30, 2023 and December 31, 2022, respectively. The leases have an average imputed interest rate of 7.32% per annum and are payable monthly with the final payments due between September of 2026 and May of 2030.

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30,   September 30,   September 30, 
   2023   2022   2023   2022 
Finance Lease cost:                    

Amortization of Right-of-Use assets

  $39,000   $
-
   $84,000   $
-
 
Interest on lease liabilities   17,000    
-
    33,000    
-
 
Total lease Costs  $56,000   $
-
   $117,000   $
-
 
                     
Other Information:                    
Cash Paid for amounts included in the measurement lease liabilities:                    
Financing cash flow from finance lease obligations  $39,000   $9,000   $84,000   $9,000 
                     
Supplemental disclosure of non-cash activity                    
Acquisition of finance lease asset  $679,000   $
-
   $679,000   $
-
 

 

As of September 30, 2023, the aggregate future minimum finance lease payments, including imputed interest are as follows:

 

For the year ending  Amount 
December 31, 2023 (remainder of the year)  $56,000 
December 31, 2024   224,000 
December 31, 2025   224,000 
December 31, 2026   199,000 
December 31, 2027   124,000 
December 31, 2028   124,000 
Thereafter   177,000 
Total future minimum finance lease payments   1,128,000 
Less: imputed interest   (205,000)
Less: Current portion   (162,000)
Long-term portion  $761,000 

 

Loan Payable – Financed Asset

 

The Company financed the purchase of a delivery vehicle in July 2020. The loan obligation totaled $24,000 and $30,000 as of September 30, 2023 and December 31, 2022, respectively. The loan bears no interest and a final payment is due and payable for all unpaid principal on July 20, 2026.

 

The future minimum loan payments are as follows:

 

For the year ending  Amount 
December 31, 2023 (remainder of the year)  $3,000 
December 31, 2024   9,000 
December 31, 2025   9,000 
December 31, 2026   4,000 
Loans Payable - financed assets   25,000 
Less: Current portion   (9,000)
Long-term portion  $16,000 

 

Related Party Notes Payable

 

Taglich Brothers, Inc. is a corporation co-founded by two directors of the Company, Michael and Robert Taglich.

 

Taglich Brothers, Inc. has acted as placement agent for various debt and equity financing transactions and has received cash and equity compensation for their services.

 

From 2016 through 2020, the Company entered into various subordinated notes payable and convertible subordinated notes payable with Michael and Robert Taglich. These notes resulted in proceeds to the Company totaling $6,550,000. In connection with these notes, Michael and Robert were issued a total of 355,082 shares of common stock and Taglich Brothers Inc. was issued promissory notes totaling $554,000 for placement agency fees. At December 31, 2020, related party notes payable totaled $6,012,000 and accrued interest totaled $400,000.

 

On January 1, 2021, the related party subordinated notes due to Michael and Robert Taglich and Taglich Brothers, Inc., were amended to include all accrued interest through December 31, 2020 in the principal balance of the notes. Per the terms of the Webster Facility, these notes remain subordinate to the Webster Facility and the outstanding principal amount of the notes and any accrued but unpaid interest is due on July 1, 2026. Approximately $2,732,000 of the related party convertible subordinated notes can be converted at the option of the holder into Common Stock of the Company at $15.00 per share and bears interest at a rate of 6% per annum, while the remaining $2,080,000 of the related party convertible subordinated notes can be converted at the option of the holder into common stock of the Company at $9.30 per share and bears interest rate of 7% per annum. The subordinated notes which are not convertible bear interest at the rate of 12% per annum. There are no periodic principal payments due on the subordinated notes payable and convertible subordinated notes payable. Under the terms of the Webster Facility, as amended, the Company is now allowed, subject to certain limitations, to make principal payments of $250,000 per quarter of this subordinated debt.

 

For the three and nine months ended September 30, 2023 no principal payments have been made on these notes. For the three and nine months ended September 30, 2022, a principal payment of $250,000 was made against the Subordinated Notes due to Michael Taglich. This payment was made pursuant to the conditions set forth in the Webster Facility, as amended.

 

The note holders and the principal balance of the notes of September 30, 2023 are shown below:

 

   Michael
Taglich,
   Robert
Taglich,
   Taglich
Brothers,
     
   Chairman   Director   Inc.   Total 
Convertible Subordinated Notes  $2,666,000   $1,905,000   $241,000   $4,812,000 
Subordinated Notes   1,000,000    350,000    
-
    1,350,000 
Total  $3,666,000   $2,255,000   $241,000   $6,162,000 

 

Interest expense on all related party notes payable for the three months ended September 30, 2023 and 2022 was $118,000 and $118,000, respectively, and $354,000 and $369,000 for the nine months ended September 30, 2023 and 2022, respectively.

v3.23.3
Stockholders’ Equity
9 Months Ended
Sep. 30, 2023
Stockholders’ Equity [Abstract]  
STOCKHOLDERS’ EQUITY

Note 6. STOCKHOLDERS’ EQUITY

 

Common Stock – Issuance of Securities

 

The Company issued 15,230 and 7,715 shares of common stock in payment of director fees totaling $54,000 and $54,000 for the three months ended September 30, 2023 and 2022, respectively, and 41,890 and 19,666 shares totaling $162,000 and $162,000 for the nine months ended September 30, 2023 and 2022, respectively.

  

During the fourth quarter of 2023, the Company issued 13,218 shares of common stock in payment of directors’ fees totaling $54,000.

 

2022 Equity Incentive Plan

 

At the 2023 annual meeting of shareholders, an amendment to the Air Industries Group 2022 Equity Incentive Plan, was approved. The amendment increased the number of shares of the Company’s common stock, par value $.001 per share, that are available for issuance by 250,000 shares from 100,000 shares to 350,000.

v3.23.3
Contingencies
9 Months Ended
Sep. 30, 2023
Contingencies [Abstract]  
CONTINGENCIES

Note 7. CONTINGENCIES

 

On October 2, 2018, Contract Pharmacal Corp. (“Contract Pharmacal”) commenced an action, relating to a Sublease entered into between the Company and Contract Pharmacal in May 2018 with respect to the property that was formerly occupied by the Company’s former subsidiary WMI, at 110 Plant Avenue, Hauppauge, New York. In the action Contract Pharmacal sought damages for an amount in excess of $1,000,000 for the Company’s failure to make the entire premises available by the Sublease commencement date. On July 8, 2021, the Court denied Contract Phamacal’s motion for summary judgement. In the Order, the court granted Contract Pharmacal’s Motions to drop its claim for specific performance and to amend its Complaint to reduce its claim for damages to $700,000. Subsequently, Contact Pharmacal moved to amend its Complaint. The Company opposed and the Court denied the request to amend the Complaint. Contract Pharmacal filed a Motion to reargue which the Court denied on November 30, 2021. On March 10, 2022, Contract Pharmacal filed an appeal to the Court’s decision with the Appellate Division which the Company has opposed. The argument of the appeal filed by Contract Pharmacal was heard by the Appellate Division on November 9, 2023. The Appellate Division has yet to render a decision with respect to Contract Phamacal’s appeal. The Company disputes the validity of the claims asserted by Contract Pharmacal and intends to contest them vigorously.

v3.23.3
Income Taxes
9 Months Ended
Sep. 30, 2023
Income Taxes [Abstract]  
INCOME TAXES

Note 8. INCOME TAXES

 

The Company recorded no income tax expense for the three and nine months ended September 30, 2023 and 2022 because the estimated annual effective tax rate was zero. In determining the estimated annual effective income tax rate, the Company analyzes various factors, including projections of the Company’s annual earnings and taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, the ability to use tax credits and net operating loss carry forwards, and available tax planning alternatives.

 

As of September 30, 2023, and December 31, 2022, the Company provided a full valuation allowance against its net deferred tax assets since the Company believes it is more likely than not that its deferred tax assets will not be realized.

v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

Note 9. SUBSEQUENT EVENTS

 

On November 21, 2023, the Company received a notice from NYSE American (the “Exchange”) stating that the Company is not in compliance with the continued listing standards of the Exchange under the timely filing criteria included in Section 1007 of the NYSE American Company Guide because the Company failed to file by the extended due date of November 20, 2023, its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “Form 10-Q”).

 

In accordance with Section 1007 of the Company Guide, the Company will have six months from the date of the filing delinquency, or until May 20, 2024 (the “Initial Cure Period”), to file the Form 10-Q with the Securities and Exchange Commission. If the Company fails to file the Form 10-Q during the Initial Cure Period, the Exchange may, in its sole discretion, provide an additional six-month cure period depending on the Company’s specific circumstances.

 

Upon filing of the Form 10-Q, the Company will cure this delinquency.

v3.23.3
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Accounts Receivable

Accounts Receivable

Accounts receivable are carried at the original invoice amount less an estimate made for credit losses based on a review of all outstanding amounts on a quarterly basis. Management determines the allowance for credit losses by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, current economic conditions and other relevant factors, including specific reserves for certain accounts. Accounts receivable are written off when deemed uncollectible.  Bad debt expenses are recorded in selling, general, and administrative expense.

 

Inventory Valuation

Inventory Valuation

The Company values inventory at the lower of cost on a first-in-first-out basis or estimated net realizable value.

The Company generally purchases raw materials and supplies uniquely suited to the production of larger more complex parts, such as landing gear, only when non-cancellable contracts for orders have been received for finished goods. It occasionally produces larger more complex products, such as landing gear, in excess of purchase order quantities in anticipation of future purchase order demand, when it is economically advantageous to do so, since historically this excess has been used in fulfilling future purchase orders. The Company purchases supplies and materials useful in a variety of products as deemed necessary even though orders have not been received. The Company periodically evaluates inventory items not secured by purchase orders and establishes write-downs to estimated net realizable value for excess quantities, slow-moving goods, obsolescence and for other impairments of value.

Inventories consist of the following at:

   September 30,   December 31, 
   2023   2022 
         
Raw Materials  $4,836,000   $4,198,000 
Work In Progress   16,337,000    20,488,000 
Finished Goods   13,415,000    10,748,000 
Reserve   (3,240,000)   (3,613,000)
Total Inventory  $31,348,000   $31,821,000 
Credit and Concentration Risks

Credit and Concentration Risks

There were three customers that represented 60.8% and two customers that represented 63.9% of total net sales for the three months ended September 30, 2023 and 2022, respectively. This is set forth in the table below.

  Percentage of Sales 
   September 30,   September 30, 
Customer  2023   2022 
         
1   31.9%   ** 
2   18.0%   ** 
3   10.9%   ** 
4   *    40.7%
5   *    23.2%
* Customer was less than 10% of sales for the three months ended September 30, 2023
** Customer was less than 10% of sales for the three months ended September 30, 2022

There were four customers that represented 62.9% and three customers that represented 68.9% of total sales for the nine months ended September 30, 2023 and 2022, respectively. This is set forth in the table below.

  Percentage of Sales 
   September 30,   September 30, 
Customer  2023   2022 
         
1   24.7%   19.5%
2   17.3%   32.5%
3   10.9%   ** 
4   10.0%   ** 
5   *    16.9%
* Customer was less than 10% of sales for the nine months ended September 30, 2023
** Customer was less than 10% of sales for the nine months ended September 30, 2022

 

There were three customers that represented 56.7% and 70.3% of gross accounts receivable at September 30, 2023 and December 31, 2022, respectively. This is set forth in the table below.

   Percentage of Accounts Receivables 
   September 30,   December 31, 
Customer  2023   2022 
         
1   23.2%   33.1%
2   20.0%   23.6%
3   13.5%   ** 
4   *    13.6%
* Customer was less than 10% of accounts receivable at September 30, 2023
** Customer was less than 10% of accounts receivable at September 30, 2022
Disaggregation of Revenue

Disaggregation of Revenue

The following table summarizes revenue from contracts with customers for the three and nine month periods ending September 30, 2023 and 2022:

   Three Months Ended   Nine Months Ended 
Product  September 30,
2023
   September 30,
2022
   September 30,
2023
   September 30,
2022
 
                 
Military  $10,144,000   $11,266,000   $31,513,000   $33,399,000 
Commercial   2,149,000    2,012,000    6,534,000    5,949,000 
                     
Total  $12,293,000   $13,278,000   $38,047,000   $39,348,000 
Cash

Cash

During the period, the Company had occasionally maintained balances in its bank accounts that were in excess of the FDIC limit. The Company has not experienced any losses on these accounts.

Major Suppliers

Major Suppliers

The Company has several key sole-source suppliers of various parts or services that are important for one or more of its products. These suppliers are its only source for such parts or services and, therefore, in the event any of them were to go out of business or be unable to provide parts or services for any reason, its business could be severely harmed.

Customer Deposits

Customer Deposits

The Company receives advance payments on certain contracts with the remainder of the contract balance due upon shipment of the final product once the customer inspects and approves the product for shipment. At that time, the entire amount will be recognized as revenue and the deposit will be applied to the customer’s invoice.

At September 30, 2023 and December 31, 2022, customer deposits were $3,476,000 and $781,000 respectively. The Company recognized revenue of $147,000 and $461,000 during the three and nine months ended September 30, 2023, respectively, that was included in the customer deposits balance as of December 31, 2022. The Company recognized revenue of $73,000 and $126,000 during the three and nine months ended September 30, 2022, respectively, that was included in the customer deposits balance as of December 31, 2021.

 

Backlog

Backlog

Backlog represents executed non-cancellable contracts that represent firm orders that are deliverable over the next 18- month period. As of September 30, 2023, backlog relating to remaining performance obligations in contracts was approximately $66,900,000. We expect to recognize revenue amounts in future periods related to these remaining performance obligations as follows: approximately $11,900,000 to $13,900,000 of our backlog during the remainder of 2023, approximately $48,500,000 from January 1, 2024 through December 31, 2024, and approximately $3,000,000 to $4,500,000 from January 1, 2025 through March 31, 2025. This expectation is based on the Company’s belief that raw material will be delivered on time from its suppliers, and that its customers will accept delivery as scheduled.

Contract Costs Receivable

Contract Costs Receivable

Contract costs receivable represent costs to be reimbursed from a terminated contract. Contract costs receivable totals $296,000 at both September 30, 2023 and December 31, 2022.

Leases

Leases

The Company accounts for leases under ASC 842, “Leases.” All leases are required to be recorded on the balance sheet and are classified as either operating leases or finance leases. The lease classification affects the expense recognition in the condensed consolidated statement of operations. Operating lease charges are recorded entirely in operating expenses. Finance lease charges are split, where amortization of the right-of- use asset is recorded in operating expenses and an implied interest component is recorded in interest expense. See Note 4.

Earnings (Loss) per share

Earnings (Loss) per share

Basic earnings (loss) per share (“EPS”) is computed by dividing the net income (loss) applicable to common stockholders by the weighted-average number of shares of common stock outstanding for the period.

For purposes of calculating diluted earnings per common share, the numerator includes net income plus interest on convertible notes payable assumed converted as of the first day of the period. The denominator includes both the weighted-average number of shares of common stock outstanding during the period and the number of common stock equivalents if the inclusion of such common stock equivalents is dilutive. Dilutive common stock equivalents potentially include stock options and warrants using the treasury stock method and convertible notes payable using the if-converted method. 

The following securities have been excluded from the calculation as the exercise price was greater than the average market price of the common shares:

   Three and Nine Months
Ended
 
   September 30,   September 30, 
   2023   2022 
         
Stock options   462,870    305,350 
Warrants   -    76,000 
    462,870    381,350 

 

The following securities have been excluded from the calculation because the effect of including these potential shares was anti-dilutive due to the net loss incurred during these periods:

   Three and Nine Months Ended 
   September 30,   September 30, 
   2023   2022 
         
Stock options   
-
    
-
 
Convertible notes payable   405,800    405,800 
    405,800    405,800 
Stock-Based Compensation

Stock-Based Compensation

The Company accounts for stock-based compensation in accordance with FASB ASC 718, “Compensation – Stock Compensation.” Under the fair value recognition provision of the ASC, stock-based compensation cost is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options and warrants granted using the Black-Scholes-Merton option pricing model. Stock-based compensation expense for employees amounted to $28,000 and $55,000 for the three months ended September 30, 2023 and 2022, respectively, and $260,000 and $262,000 for the nine months ended September 30, 2023 and 2022, respectively. Stock compensation expense for directors amounted to $54,000 and $54,000 for the three months ended September 30, 2023 and 2022, respectively, and $162,000 and $162,000 for the nine months ended September 30, 2023 and 2022, respectively. Stock compensation expense for employees and directors was included in operating expenses on the accompanying Condensed Consolidated Statements of Operations.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

Effective January 1, 2023, the Company adopted ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326) (“ASU 2016-13”), which significantly changes how entities will account for credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. ASU 2016-13 replaces the existing incurred loss model with an expected credit loss model that requires entities to estimate an expected lifetime credit loss on most financial assets and certain other instruments. Under ASU 2016-13 credit impairment is recognized as an allowance for credit losses, rather than as a direct write-down of the amortized cost basis of a financial asset. The impairment allowance is a valuation account deducted from the amortized cost basis of financial assets to present the net amount expected to be collected on the financial asset. The allowance for credit losses must be adjusted for management’s current estimate at each reporting date. The new guidance provides no threshold for recognition of impairment allowance. Therefore, entities must also measure expected credit losses on assets that have a low risk of loss. For instance, trade receivables that are either current or not yet due may not require an allowance reserve under currently generally accepted accounting principles, but under the new standard, the Company will have to estimate an allowance for expected credit losses on trade receivables under ASU 2016-13. The adoption of ASU 2016-13 did not have a material effect on the Company’s financial statements.

The Company does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed consolidated financial statements.

v3.23.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Schedule of Activity for the Allowance for Credit Losses The activity for the allowance for credit losses during the nine months ended September 30, 2023 and 2022 is set forth in the table below
   September 30, 
   2023   2022 
Balance, January 1,  $281,000   $594,000 
           
Provision (Reversal)   67,000    (99,000)
Write-offs   
    
 
Balance, September 30  $348,000   $493,000 
Schedule of Inventories Inventories consist of the following at:
   September 30,   December 31, 
   2023   2022 
         
Raw Materials  $4,836,000   $4,198,000 
Work In Progress   16,337,000    20,488,000 
Finished Goods   13,415,000    10,748,000 
Reserve   (3,240,000)   (3,613,000)
Total Inventory  $31,348,000   $31,821,000 
Schedule of Activity for the Allowance for Credit Losses There were three customers that represented 60.8% and two customers that represented 63.9% of total net sales for the three months ended September 30, 2023 and 2022, respectively. This is set forth in the table below.
  Percentage of Sales 
   September 30,   September 30, 
Customer  2023   2022 
         
1   31.9%   ** 
2   18.0%   ** 
3   10.9%   ** 
4   *    40.7%
5   *    23.2%
* Customer was less than 10% of sales for the three months ended September 30, 2023
** Customer was less than 10% of sales for the three months ended September 30, 2022
  Percentage of Sales 
   September 30,   September 30, 
Customer  2023   2022 
         
1   24.7%   19.5%
2   17.3%   32.5%
3   10.9%   ** 
4   10.0%   ** 
5   *    16.9%
* Customer was less than 10% of sales for the nine months ended September 30, 2023
** Customer was less than 10% of sales for the nine months ended September 30, 2022

 

   Percentage of Accounts Receivables 
   September 30,   December 31, 
Customer  2023   2022 
         
1   23.2%   33.1%
2   20.0%   23.6%
3   13.5%   ** 
4   *    13.6%
* Customer was less than 10% of accounts receivable at September 30, 2023
** Customer was less than 10% of accounts receivable at September 30, 2022
Schedule of Revenue from Contracts with Customers The following table summarizes revenue from contracts with customers for the three and nine month periods ending September 30, 2023 and 2022:
   Three Months Ended   Nine Months Ended 
Product  September 30,
2023
   September 30,
2022
   September 30,
2023
   September 30,
2022
 
                 
Military  $10,144,000   $11,266,000   $31,513,000   $33,399,000 
Commercial   2,149,000    2,012,000    6,534,000    5,949,000 
                     
Total  $12,293,000   $13,278,000   $38,047,000   $39,348,000 
Schedule of Average Market Price of The Common Shares The following securities have been excluded from the calculation as the exercise price was greater than the average market price of the common shares:
   Three and Nine Months
Ended
 
   September 30,   September 30, 
   2023   2022 
         
Stock options   462,870    305,350 
Warrants   -    76,000 
    462,870    381,350 

 

Schedule of Anti-Dilutive Due to the Net Loss The following securities have been excluded from the calculation because the effect of including these potential shares was anti-dilutive due to the net loss incurred during these periods:
   Three and Nine Months Ended 
   September 30,   September 30, 
   2023   2022 
         
Stock options   
-
    
-
 
Convertible notes payable   405,800    405,800 
    405,800    405,800 
v3.23.3
Property and Equipment (Tables)
9 Months Ended
Sep. 30, 2023
Property and Equipment [Abstract]  
Schedule of Property and Equipment The components of property and equipment at September 30, 2023 and December 31, 2022 consisted of the following:
   September 30,   December 31, 
   2023   2022 
         
Land  $300,000   $300,000 
Buildings and Improvements   2,206,000    1,789,000 
Machinery and Equipment   24,681,000    23,566,000 
Finance Lease Right-of-Use Assets - Machinery and Equipment   1,054,000    375,000 
Tools and Instruments   13,972,000    13,744,000 
Automotive Equipment   266,000    266,000 
Furniture and Fixtures   310,000    290,000 
Leasehold Improvements   1,025,000    941,000 
Computers and Software   605,000    604,000 
Total Property and Equipment   44,419,000    41,875,000 
Less: Accumulated Depreciation   (35,134,000)   (33,282,000)
Property and Equipment, net  $9,285,000   $8,593,000 
v3.23.3
Leases (Tables)
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Schedule of Remaining Lease Terms The Company has operating leases for leased office and manufacturing facilities. The leases have remaining lease terms of one to five years, some of which include options to extend or terminate the leases.
   Three Months Ended   Nine Months Ended 
   September 30,   September 30,   September 30,   September 30, 
   2023   2022   2023   2022 
Operating lease cost:  $295,000   $271,000   $839,000   $834,000 
Total lease cost  $295,000   $271,000   $839,000   $834,000 
                     
Other Information                    
Cash paid for amounts included in the measurement lease liability:  $258,000   $250,000   $773,000   $750,000 
Operating cash flow from operating leases  $258,000   $250,000   $773,000   $750,000 
Schedule of Operating Cash Flow from Operating Leases Operating cash flow from operating leases
   September 30,   December 31, 
   2023   2022 
Weighted Average Remaining Lease Term - in years   2.91    3.64 
Weighted Average discount rate - %   9.06%   8.89%

 

Schedule of Aggregate Undiscounted Cash Flows of Operating Lease Payments The aggregate undiscounted cash flows of operating lease payments for leases with remaining terms greater than one year are as follows:
   Amount 
December 31, 2023 (remainder of year)  $265,000 
December 31, 2024   1,070,000 
December 31, 2025   992,000 
December 31, 2026   730,000 
Total future minimum lease payments   3,057,000 
Less: discount   (388,000)
Total operating lease maturities   2,669,000 
Less: current portion of operating lease liabilities   (854,000)

Total long-term portion of operating lease maturities

  $1,815,000 
v3.23.3
Debt (Tables)
9 Months Ended
Sep. 30, 2023
Debt [Abstract]  
Schedule of Debt Notes payable, related party notes payable and finance lease obligations consist of the following:
    September 30,     December 31,  
    2023     2022  
             
Revolving loan to Webster Bank   $ 8,444,000     $ 13,352,000  
Term loan, Webster     5,275,000       5,396,000  
Connecticut Green Bank loan     393,000       -  
Finance lease obligations     923,000       328,000  
Loans payable - financed assets     24,000       30,000  
Related party notes payable     6,162,000       6,162,000  
Subtotal     21,221,000       25,268,000  
Less: Current portion     (13, 903,000 )     (14,477,000 )
Long Term Portion   $ 7, 318,000     $ 10,791,000  
Schedule of Payments Due Under the Term Loan The below table shows the timing of payments due under the Term Loan:
For the year ending  Amount 
December 31, 2023 (remainder of the year)  $236,000 
December 31, 2024   945,000 
December 31, 2025   4,143,000 
Webster Term Loan payable   5,324,000 
Less: debt issuance costs   (49,000)
Total Webster Term Loan payable, net of debt issuance costs   5,275,000 
Less: Current portion of Webster Term Loan payable   5,275,000 
Total long-term portion of Webster Term Loan payable  $
-
 
Schedule of Finance Lease Paid The leases have an average imputed interest rate of 7.32% per annum and are payable monthly with the final payments due between September of 2026 and May of 2030.
   Three Months Ended   Nine Months Ended 
   September 30,   September 30,   September 30,   September 30, 
   2023   2022   2023   2022 
Finance Lease cost:                    

Amortization of Right-of-Use assets

  $39,000   $
-
   $84,000   $
-
 
Interest on lease liabilities   17,000    
-
    33,000    
-
 
Total lease Costs  $56,000   $
-
   $117,000   $
-
 
                     
Other Information:                    
Cash Paid for amounts included in the measurement lease liabilities:                    
Financing cash flow from finance lease obligations  $39,000   $9,000   $84,000   $9,000 
                     
Supplemental disclosure of non-cash activity                    
Acquisition of finance lease asset  $679,000   $
-
   $679,000   $
-
 

 

Schedule of Aggregate Future Minimum Finance Lease Payment As of September 30, 2023, the aggregate future minimum finance lease payments, including imputed interest are as follows:
For the year ending  Amount 
December 31, 2023 (remainder of the year)  $56,000 
December 31, 2024   224,000 
December 31, 2025   224,000 
December 31, 2026   199,000 
December 31, 2027   124,000 
December 31, 2028   124,000 
Thereafter   177,000 
Total future minimum finance lease payments   1,128,000 
Less: imputed interest   (205,000)
Less: Current portion   (162,000)
Long-term portion  $761,000 
For the year ending  Amount 
December 31, 2023 (remainder of the year)  $3,000 
December 31, 2024   9,000 
December 31, 2025   9,000 
December 31, 2026   4,000 
Loans Payable - financed assets   25,000 
Less: Current portion   (9,000)
Long-term portion  $16,000 
Schedule of Note Holders and the Principal Balance The note holders and the principal balance of the notes of September 30, 2023 are shown below:
   Michael
Taglich,
   Robert
Taglich,
   Taglich
Brothers,
     
   Chairman   Director   Inc.   Total 
Convertible Subordinated Notes  $2,666,000   $1,905,000   $241,000   $4,812,000 
Subordinated Notes   1,000,000    350,000    
-
    1,350,000 
Total  $3,666,000   $2,255,000   $241,000   $6,162,000 
v3.23.3
Formation, Basis of Presentation and Going Concern (Details)
9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Formation and Basis of Presentation [Line Items]    
Aggregate debt $ 13,715,000  
Net cash provided by operating activities $ 7,093,000 $ (73,000)
Minimum [Member]    
Formation and Basis of Presentation [Line Items]    
Fixed charge coverage ratio 0.95  
Maximum [Member]    
Formation and Basis of Presentation [Line Items]    
Fixed charge coverage ratio 1  
v3.23.3
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2022
Summary of Significant Accounting Policies [Line Items]              
Customer deposits $ 3,476,000   $ 3,476,000       $ 781,000
Revenue recognized from customer deposits 147,000 $ 73,000 461,000 $ 126,000      
Backlog relating to remaining performance obligations in contracts 66,900,000   66,900,000        
Contract costs receivable     296,000       $ 296,000
Stock based compensation 28,000 55,000 260,000 $ 262,000      
Stock compensation expense $ 54,000 $ 54,000          
Minimum [Member]              
Summary of Significant Accounting Policies [Line Items]              
Expected revenue recognition from backlog     11,900,000        
Maximum [Member]              
Summary of Significant Accounting Policies [Line Items]              
Expected revenue recognition from backlog     $ 13,900,000        
Three Customers [Member] | Net Sales [Member] | Customer Concentration Risk [Member]              
Summary of Significant Accounting Policies [Line Items]              
Concentration risk percentage 60.80%     68.90%      
Three Customers [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]              
Summary of Significant Accounting Policies [Line Items]              
Concentration risk percentage     56.70%       70.30%
Two Customers [Member] | Net Sales [Member] | Customer Concentration Risk [Member]              
Summary of Significant Accounting Policies [Line Items]              
Concentration risk percentage   63.90%          
Customer [Member] | Net Sales [Member] | Customer Concentration Risk [Member]              
Summary of Significant Accounting Policies [Line Items]              
Concentration risk percentage 10.00% 10.00% 10.00% 10.00%      
Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]              
Summary of Significant Accounting Policies [Line Items]              
Concentration risk percentage     10.00% 10.00%      
Four Customers [Member] | Net Sales [Member] | Customer Concentration Risk [Member]              
Summary of Significant Accounting Policies [Line Items]              
Concentration risk percentage     62.90%        
Director [Member]              
Summary of Significant Accounting Policies [Line Items]              
Stock compensation expense     $ 162,000 $ 162,000      
Forecast [Member]              
Summary of Significant Accounting Policies [Line Items]              
Expected revenue recognition from backlog           $ 48,500,000  
Forecast [Member] | Minimum [Member]              
Summary of Significant Accounting Policies [Line Items]              
Expected revenue recognition from backlog         $ 3,000,000    
Forecast [Member] | Maximum [Member]              
Summary of Significant Accounting Policies [Line Items]              
Expected revenue recognition from backlog         $ 4,500,000    
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Activity for the Allowance for Credit Losses - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Schedule Of Activity For The Allowance For Credit Losses Abstract    
Balance, Beginning $ 281,000 $ 594,000
Provision (Reversal) 67,000 (99,000)
Write-offs
Balance, Ending $ 348,000 $ 493,000
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Inventories - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Schedule of Inventories [Line Item]    
Raw Materials $ 4,836,000 $ 4,198,000
Work In Progress 16,337,000 20,488,000
Finished Goods 13,415,000 10,748,000
Reserve (3,240,000) (3,613,000)
Total Inventory $ 31,348,000 $ 31,821,000
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Customers that Represented
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Sales [Member] | Customer Concentration Risk [Member] | Customer One [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage 31.90% [1]      
Sales [Member] | Customer Concentration Risk [Member] | Customers Two [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage 18.00% [1]      
Sales [Member] | Credit Concentration Risk [Member] | Customer One [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     24.70% 19.50%  
Sales [Member] | Credit Concentration Risk [Member] | Customers Two [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     17.30% 32.50%  
Sales [Member] | Credit Concentration Risk [Member] | Customers Three [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage 10.90% [1] 10.90% [2]  
Sales [Member] | Credit Concentration Risk [Member] | Customer Four [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage [3] 40.70% 10.00% [2]  
Sales [Member] | Credit Concentration Risk [Member] | Customers Five [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage [3] 23.20% [4] 16.90%  
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Customer One [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     23.20%   33.10%
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Customers Two [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     20.00%   23.60%
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Customers Three [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     13.50%   [5]
Accounts Receivable [Member] | Credit Concentration Risk [Member] | Customer Four [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     [6]   13.60%
[1] Customer was less than 10% of sales for the three months ended September 30, 2022
[2] Customer was less than 10% of sales for the nine months ended September 30, 2022
[3] Customer was less than 10% of sales for the three months ended September 30, 2023
[4] Customer was less than 10% of sales for the nine months ended September 30, 2023
[5] Customer was less than 10% of accounts receivable at September 30, 2022
[6] Customer was less than 10% of accounts receivable at September 30, 2023
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Revenue from Contracts with Customers - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Schedule of Revenue from Contracts with Customers [Line Item]        
Total $ 12,293,000 $ 13,278,000 $ 38,047,000 $ 39,348,000
Military [Member]        
Schedule of Revenue from Contracts with Customers [Line Item]        
Total 10,144,000 11,266,000 31,513,000 33,399,000
Commercial [Member]        
Schedule of Revenue from Contracts with Customers [Line Item]        
Total $ 2,149,000 $ 2,012,000 $ 6,534,000 $ 5,949,000
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Average Market Price of the Common Shares - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Schedule of Average Market Price of the Common Shares [Line Item]    
Stock options $ 462,870 $ 305,350
Warrants   76,000
Total $ 462,870 $ 381,350
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Anti-Dilutive Due to the Net Loss - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Schedule of Anti-Dilutive Due to the Net Loss [Line Item]    
Stock options
Convertible notes payable 405,800 405,800
Total $ 405,800 $ 405,800
v3.23.3
Property and Equipment (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Property and Equipment [Line Items]          
Depreciation expense $ 614,000 $ 598,000 $ 1,853,000 $ 1,906,000  
Property, Plant and Equipment [Member]          
Property and Equipment [Line Items]          
Accumulated depreciation $ 46,000   $ 46,000   $ 0
v3.23.3
Property and Equipment (Details) - Schedule of Property and Equipment - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Total Property and Equipment $ 44,419,000 $ 41,875,000
Less: Accumulated Depreciation (35,134,000) (33,282,000)
Property and Equipment, net 9,285,000 8,593,000
Land [Member]    
Property, Plant and Equipment [Line Items]    
Total Property and Equipment 300,000 300,000
Buildings and Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Total Property and Equipment 2,206,000 1,789,000
Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total Property and Equipment 24,681,000 23,566,000
Finance Lease Right-of-Use Assets - Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total Property and Equipment 1,054,000 375,000
Tools and Instruments [Member]    
Property, Plant and Equipment [Line Items]    
Total Property and Equipment 13,972,000 13,744,000
Automotive Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Total Property and Equipment 266,000 266,000
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Total Property and Equipment 310,000 290,000
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Total Property and Equipment 1,025,000 941,000
Computers and Software [Member]    
Property, Plant and Equipment [Line Items]    
Total Property and Equipment $ 605,000 $ 604,000
v3.23.3
Leases (Details)
Sep. 30, 2023
Minimum [Member]  
Leases [Abstract]  
Lease terms 1 year
Maximum [Member]  
Leases [Abstract]  
Lease terms 5 years
v3.23.3
Leases (Details) - Schedule of Remaining Lease Terms - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Schedule of Remaining Lease Terms [Abstract]        
Operating lease cost: $ 295,000 $ 271,000 $ 839,000 $ 834,000
Total lease cost 295,000 271,000 839,000 834,000
Other Information        
Cash paid for amounts included in the measurement lease liability: 258,000 250,000 773,000 750,000
Operating cash flow from operating leases $ 258,000 $ 250,000 $ 773,000 $ 750,000
v3.23.3
Leases (Details) - Schedule of Operating Cash Flow from Operating Leases
Sep. 30, 2023
Dec. 31, 2022
Schedule of Operating and Finance Leases [Abstract]    
Weighted Average Remaining Lease Term - in years 2 years 10 months 28 days 3 years 7 months 20 days
Weighted Average discount rate - % 9.06% 8.89%
v3.23.3
Leases (Details) - Schedule of Aggregate Undiscounted Cash Flows of Operating Lease Payments
Sep. 30, 2023
USD ($)
Schedule of Aggregate Undiscounted Cash Flows of Operating Lease Payments [Abstract]  
December 31, 2023 (remainder of year) $ 265,000
December 31, 2024 1,070,000
December 31, 2025 992,000
December 31, 2026 730,000
Total future minimum lease payments 3,057,000
Less: discount (388,000)
Total operating lease maturities 2,669,000
Less: current portion of operating lease liabilities (854,000)
Total long-term portion of operating lease maturities $ 1,815,000
v3.23.3
Debt (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2023
Feb. 28, 2023
Jan. 04, 2023
Dec. 15, 2022
May 17, 2022
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Aug. 16, 2023
Dec. 31, 2019
Debt (Details) [Line Items]                            
Expires date               Dec. 30, 2025            
Revolving line of credit loan                           $ 20,000,000
Term loan                           5,000,000
Equipment line of credit                           $ 2,000,000
Line of credit amount     $ 739,500 $ 877,913                    
Principal payments $ 8,804 $ 10,451                        
Due date Dec. 30, 2025 Dec. 30, 2025                        
Revolving line of credit, current           $ 8,444,000   $ 8,444,000   $ 13,352,000        
Term loan           5,275,000   5,275,000            
Equipment line of credit remaining available           382,000   382,000            
Withdrawn amount                   878,000        
Interest expense           $ 380,000 $ 204,000 $ 1,084,000 $ 506,000          
Excess cash flow percentage               25.00%            
Term loan         $ 5,000,000         195,000        
Generating proceeds         1,945,000                  
Capital expenditure line of credit         2,000,000                  
Amendment fee paid         20,000                  
Webster facility, description               (i) 3.50% and (ii) a rate per annum equal to the rate per annum published from time to time in the “Money Rates” table of the Wall Street Journal (or such other presentation within The Wall Street Journal as may be adopted hereafter for such information) as the base or prime rate for corporate loans at the nation’s largest commercial bank, less sixty-five hundredths (-0.65%) of one percent per annum.            
Average interest rate           7.78% 4.70% 7.44% 3.94%          
Fixed coverage charge ratio               1.25 to 1.00            
Description of fifth amendment               the Company entered into the Fifth Amendment to the Webster Facility (“Fifth Amendment”). The amendment waived the default caused by the failure to achieve the required Fixed Charge Coverage Ratio for the Fiscal Quarter ended March 31, 2023 and decreased the required Fixed Charge Coverage Ratio to 0.95 to 1.00 for the Fiscal Quarters ending June 30, 2023 and September 30, 2023. Additionally, the Fifth Amendment increased the amount of purchase money secured Debt (including Finance Leases) the Company is allowed to have outstanding at any time to $2,000,000. In connection with these changes, the Company paid an amendment fee of $10,000.            
Cumulative Advance total           $ 393,233   $ 393,233         $ 934,553  
Closing costs               $ 25,233            
Payment term loan           20 years   20 years            
Projected semi-annual payments               $ 41,000            
Finance lease               962,000            
Notes payable                       $ 6,012,000    
Amortizing amount of related party               $ 2,732,000            
Common stock per share (in Dollars per share)           $ 15   $ 15            
Related party convertible notes               $ 2,080,000            
Per share (in Dollars per share)               $ 9.3            
Subordinated debt payment allowed subject to certain limitations           $ 250,000   $ 250,000            
Interest expenses           $ 118,000 $ 118,000 $ 354,000 $ 369,000          
April 2022 [Member]                            
Debt (Details) [Line Items]                            
Excess cash flow payments                     $ 854,000      
November 2022 [Member]                            
Debt (Details) [Line Items]                            
Finance lease                   328,000        
Imputed interest rate           7.32%   7.32%            
December 2021 [Member]                            
Debt (Details) [Line Items]                            
Finance lease               $ 24,000   30,000        
2016-2020 [Member]                            
Debt (Details) [Line Items]                            
Notes proceeds               $ 6,550,000            
Common stock, shares issued (in Shares)           355,082   355,082            
Promissory notes           $ 554,000   $ 554,000            
Michael Taglich [Member]                            
Debt (Details) [Line Items]                            
Subordinated debt payment allowed subject to certain limitations           $ 250,000   $ 250,000            
Fourth Amendment [Member]                            
Debt (Details) [Line Items]                            
Principal installments amount         $ 59,524                  
Sixth Amendment [Member]                            
Debt (Details) [Line Items]                            
Debt description               The Sixth Amendment allows for the Fixed Charge Coverage Ratio to be calculated on a rolling basis (w) for the Fiscal Quarter Ending December 31, 2023, three month basis, (x) for the Fiscal Quarter Ending March 31, 2024, six month basis, (y) for the Fiscal Quarter Ending June 30, 2024, nine month basis, and (z) for all other Fiscal Quarters, twelve month basis. Additionally, the Fixed Charge Coverage Ratio shall not be less than (i) 0.95 to 1.00 for the Fiscal Quarters ending June 30, 2023, September 30, 2023, and December 31, 2023, (ii) 1.10 to 1.00 for the Fiscal Quarter ending March 31, 2024, (iii) 1.20 to 1.00 for the Fiscal Quarter ending June 30, 2024, and (iv) 1.25 to 1.00 for all other Fiscal Quarters. The Sixth Amendment has increased the Capital Expenditure limit to $2,500,000 in any Fiscal Year. In connection with these changes, the Company paid an amendment for of $20,000.            
Connecticut Green Bank [Member]                            
Debt (Details) [Line Items]                            
Interest rate percentage           5.75%   5.75%            
Michael Taglich, and Robert [Member]                            
Debt (Details) [Line Items]                            
Interest rate percentage           7.00%   7.00%            
Accrued interest                       $ 400,000    
Interest rate percentage           6.00%   6.00%            
Interest rate               12.00%            
Webster Facility [Member]                            
Debt (Details) [Line Items]                            
Debt                   18,748,000        
Revolving loan                   13,352,000        
Loan amount                   $ 5,396,000        
Webster Facility [Member] | Connecticut Green Bank [Member]                            
Debt (Details) [Line Items]                            
Interest rate percentage           5.00%   5.00%            
v3.23.3
Debt (Details) - Schedule of Debt - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Schedule of Notes Payable Related Party Notes Payable and Finance Lease Obligations [Abstract]    
Revolving loan to Webster Bank $ 8,444,000 $ 13,352,000
Term loan, Webster 5,275,000 5,396,000
Connecticut Green Bank loan 393,000
Finance lease obligations 923,000 328,000
Loans payable - financed assets 24,000 30,000
Related party notes payable 6,162,000 6,162,000
Subtotal 21,221,000 25,268,000
Less: Current portion (13,903,000) (14,477,000)
Long Term Portion $ 7,318,000 $ 10,791,000
v3.23.3
Debt (Details) - Schedule of Payments Due Under the Term Loan
Sep. 30, 2023
USD ($)
Schedule of Payments Due Under The Term Loan [Abstract]  
December 31, 2023 (remainder of the year) $ 236,000
December 31, 2024 945,000
December 31, 2025 4,143,000
Webster Term Loan payable 5,324,000
Less: debt issuance costs (49,000)
Total Webster Term Loan payable, net of debt issuance costs 5,275,000
Less: Current portion of Webster Term Loan payable 5,275,000
Total long-term portion of Webster Term Loan payable
v3.23.3
Debt (Details) - Schedule of Finance Lease Paid - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Finance Lease cost:        
Amortization of Right of Use assets $ 39,000 $ 84,000
Interest on lease liabilities 17,000 33,000
Total lease Costs 56,000 117,000
Cash Paid for amounts included in the measurement lease liabilities:        
Financing cash flow from finance lease obligations 39,000 9,000 84,000 9,000
Acquisition of finance lease asset $ 679,000 $ 679,000
v3.23.3
Debt (Details) - Schedule of Aggregate Future Minimum Finance Lease Payment - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Debt (Details) - Schedule of Aggregate Future Minimum Finance Lease Payment [Line Items]    
Less: Current portion $ (13,903,000) $ (14,477,000)
Loans Payable – Financed Assets [Member]    
Debt (Details) - Schedule of Aggregate Future Minimum Finance Lease Payment [Line Items]    
December 31, 2023 (remainder of the year) 3,000  
December 31, 2024 9,000  
December 31, 2025 9,000  
December 31, 2026 4,000  
Loans Payable - financed assets 25,000  
Less: Current portion (9,000)  
Long-term portion 16,000  
Finance Lease Obligations [Member]    
Debt (Details) - Schedule of Aggregate Future Minimum Finance Lease Payment [Line Items]    
December 31, 2023 (remainder of the year) 56,000  
December 31, 2024 224,000  
December 31, 2025 224,000  
December 31, 2026 199,000  
December 31, 2027 124,000  
December 31, 2028 124,000  
Thereafter 177,000  
Total future minimum finance lease payments 1,128,000  
Less: imputed interest (205,000)  
Less: Current portion (162,000)  
Long-term portion $ 761,000  
v3.23.3
Debt (Details) - Schedule of Note Holders and the Principal Balance
Jun. 30, 2023
USD ($)
Debt (Details) - Schedule of Note Holders and the Principal Balance [Line Items]  
Convertible Subordinated Notes $ 4,812,000
Subordinated Notes 1,350,000
Total 6,162,000
Michael Taglich, Chairman [Member]  
Debt (Details) - Schedule of Note Holders and the Principal Balance [Line Items]  
Convertible Subordinated Notes 2,666,000
Subordinated Notes 1,000,000
Total 3,666,000
Robert Taglich, Director [Member]  
Debt (Details) - Schedule of Note Holders and the Principal Balance [Line Items]  
Convertible Subordinated Notes 1,905,000
Subordinated Notes 350,000
Total 2,255,000
Taglich Brothers, Inc. [Member]  
Debt (Details) - Schedule of Note Holders and the Principal Balance [Line Items]  
Convertible Subordinated Notes 241,000
Subordinated Notes
Total $ 241,000
v3.23.3
Stockholders’ Equity (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Stockholders’ Equity [Line Items]            
Common stock shares issued   15,230 7,715 41,890 19,666  
Directors fees totaling (in Dollars)   $ 54,000 $ 54,000 $ 162,000 $ 162,000  
Common stock, par value (in Dollars per share)   $ 0.001   $ 0.001   $ 0.001
Shares available for issuance   3,289,827   3,289,827   3,247,937
Common Stock [Member]            
Stockholders’ Equity [Line Items]            
Common stock, par value (in Dollars per share)   $ 0.001   $ 0.001    
Common Stock [Member] | 2022 Equity Incentive Plan [Member]            
Stockholders’ Equity [Line Items]            
Shares available for issuance   250,000   250,000    
Common Stock [Member] | Minimum [Member] | 2022 Equity Incentive Plan [Member]            
Stockholders’ Equity [Line Items]            
Shares available for issuance   100,000   100,000    
Common Stock [Member] | Maximum [Member] | 2022 Equity Incentive Plan [Member]            
Stockholders’ Equity [Line Items]            
Shares available for issuance   350,000   350,000    
Forecast [Member]            
Stockholders’ Equity [Line Items]            
Common stock shares issued 13,218          
Directors fees totaling (in Dollars) $ 54,000          
v3.23.3
Contingencies (Details) - USD ($)
Jul. 08, 2021
Oct. 02, 2018
Contingencies [Abstract]    
Damages amount   $ 1,000,000
Damages claim $ 700,000  

Air Industries (AMEX:AIRI)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Air Industries Charts.
Air Industries (AMEX:AIRI)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Air Industries Charts.